[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 76 of about 76
1. Nohadani N, Ruf S: Assessment of vertical facial and dentoalveolar changes using panoramic radiography. Eur J Orthod; 2008 Jun;30(3):262-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of vertical facial and dentoalveolar changes using panoramic radiography.
  • The purpose of the study was to analyse longitudinal vertical facial and dentoalveolar changes using panoramic radiographs (PRs) and to compare the results with measurements on lateral cephalometric radiographs (LCRs) in order to determine whether, under certain circumstances, the radiation dose for a patient may be reduced by taking only a PR instead of a PR and a LCR.
  • Pre- and post-treatment PRs and LCRs of 30 (15 females and 15 males) orthodontically treated adolescents (mean age pre-treatment 10.9 years, post-treatment 13.4 years) were analysed using Pearson's correlation coefficients and gender differences using Fisher's z-transformation.
  • The results revealed that most variables exhibited larger absolute values on PRs than on LCRs.
  • Comparison of dentoskeletal morphology between the LCRs and the PRs revealed moderate to high, mostly statistically significant, interrelations both before and after orthodontic treatment.
  • The lowest correlations were found for the maxillary jaw base angle (NL/H; r= 0.35***) and the highest for the gonial angle (ML/RL; r = 0.90***).
  • However, when assessing the combined growth and treatment changes from before to after treatment, only weak to moderate, not statistically significant, interrelations were found between LCRs and PRs.
  • Anterior face height (AFH; r = 0.43***), the mandibular plane angle (ML/H; r = 0.06*), and the distance of the incisal tip of the most extruded mandibular incisor to the ML-line (ii-ML; r = -0.21*) were the only statistically significant parameters.
  • The average group differences for growth and treatment changes, however, were small for most parameters.
  • Analysis of vertical facial and dentoalveolar parameters on PRs delivers a moderate approximation to the situation depicted on LCRs.
  • However, PRs cannot be recommended for the analysis of individual longitudinal changes in vertical facial and dentoalveolar parameters.
  • [MeSH-major] Cephalometry / methods. Malocclusion / therapy. Maxillofacial Development. Radiography, Panoramic / methods. Vertical Dimension
  • [MeSH-minor] Adolescent. Child. Face / radiography. Female. Humans. Longitudinal Studies. Male. Orthodontics, Corrective / instrumentation. Orthodontics, Corrective / methods. Reproducibility of Results. Sensitivity and Specificity. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18209215.001).
  • [ISSN] 1460-2210
  • [Journal-full-title] European journal of orthodontics
  • [ISO-abbreviation] Eur J Orthod
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. Lazary J, Gonda X, Benko A, Gacser M, Bagdy G: Association of depressive phenotype with affective family history is mediated by affective temperaments. Psychiatry Res; 2009 Jul 30;168(2):145-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of depressive phenotype with affective family history is mediated by affective temperaments.
  • Increasing data support an association of cyclothymic temperament with bipolarity, but our knowledge about the relationship of affective temperaments (ATs) to depressive symptoms based on inheritance in a non-clinical population is limited.
  • The aim of this article was to demonstrate how ATs and affective family history relate to the depressive symptoms in a general population.
  • Subjects comprised 501 Hungarian adults who completed a background questionnaire, the TEMPS-A, the Zung Self-Rating Depression Scale (ZSDS) and the depression subscale of the Brief Symptom Inventory (BSI-D).
  • Stepwise linear regression was performed to analyse the role of ATs and affective family history (AFH(0) and AFH(1)) in the variance of ZSDS and BSI-D scores.
  • Cyclothymic, depressive and anxious temperaments have a significant role in the explained variance of depression scores, and they are all significantly related to AFH(1).
  • Significant differences were found between AFH(1) and AFH(0) groups in ZSDS and BSI-D scores, and these effects were eliminated if ATs were entered as covariates.
  • The probability of having any dominant temperament was more than two-fold in group AFH(1) compared with AFH(0) (OR=2.33).
  • Our results suggest that a crucial part of inherited factors of depression is mediated by affective temperaments.
  • [MeSH-major] Child of Impaired Parents / statistics & numerical data. Mood Disorders / genetics. Temperament / classification
  • [MeSH-minor] Adult. Child. Depression / epidemiology. Depression / genetics. Depressive Disorder / diagnosis. Depressive Disorder / epidemiology. Depressive Disorder / genetics. Family. Female. Humans. Linear Models. Male. Personality Inventory / statistics & numerical data. Phenotype. Prevalence. Psychiatric Status Rating Scales. Psychometrics. Sex Factors. Surveys and Questionnaires

  • MedlinePlus Health Information. consumer health - Mood Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19501413.001).
  • [ISSN] 0165-1781
  • [Journal-full-title] Psychiatry research
  • [ISO-abbreviation] Psychiatry Res
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  •  go-up   go-down


3. García JJ, Folpe AL: The impact of advances in molecular genetic pathology on the classification, diagnosis and treatment of selected soft tissue tumors of the head and neck. Head Neck Pathol; 2010 Mar;4(1):70-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This reviews details some ways in which molecular techniques have strengthened conventional diagnostic and management approaches to low-grade fibromyxoid sarcoma, angiomatoid (malignant) fibrous histiocytoma, and dermatofibrosarcoma protuberans, all of which may involve the head and neck region.
  • [MeSH-major] Angiomatosis / genetics. Dermatofibrosarcoma / genetics. Head and Neck Neoplasms / genetics. Histiocytoma, Benign Fibrous / genetics. Pathology, Molecular / trends. Soft Tissue Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Diagn. 2002 Feb;4(1):44-52 [11826187.001]
  • [Cites] Cancer. 1979 Dec;44(6):2147-57 [228836.001]
  • [Cites] Genes Chromosomes Cancer. 2003 May;37(1):1-19 [12661001.001]
  • [Cites] Hum Mol Genet. 2003 Sep 15;12(18):2349-58 [12915480.001]
  • [Cites] Am J Dermatopathol. 2004 Apr;26(2):141-55 [15024197.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Jul;40(3):218-28 [15139001.001]
  • [Cites] Am J Clin Pathol. 1987 Nov;88(5):615-9 [3673943.001]
  • [Cites] Genes Chromosomes Cancer. 1996 Jan;15(1):73-5 [8824728.001]
  • [Cites] Nat Genet. 1997 Jan;15(1):95-8 [8988177.001]
  • [Cites] Lab Invest. 2005 Mar;85(3):408-15 [15640831.001]
  • [Cites] Anticancer Drugs. 2005 Apr;16(4):461-6 [15746584.001]
  • [Cites] Hum Pathol. 1999 Nov;30(11):1336-43 [10571514.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1353-60 [11023096.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Sep;121(2):109-16 [11063792.001]
  • [Cites] Am J Surg Pathol. 2006 Apr;30(4):436-43 [16625088.001]
  • [Cites] Am J Surg Pathol. 2006 Sep;30(9):1077-84 [16931951.001]
  • [Cites] Clin Cancer Res. 2006 Sep 15;12(18):5356-62 [17000668.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Feb;46(2):181-91 [17117415.001]
  • [Cites] Am J Surg Pathol. 2007 Sep;31(9):1387-402 [17721195.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Dec;46(12):1051-60 [17724745.001]
  • [Cites] Clin Cancer Res. 2007 Dec 15;13(24):7322-8 [18094413.001]
  • [Cites] Int J Cancer. 2002 Aug 20;100(6):623-6 [12209598.001]
  • (PMID = 20237992.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 22
  • [Other-IDs] NLM/ PMC2825525
  •  go-up   go-down


Advertisement
4. Bishop J: Ambition and vision at student awards. Health Estate; 2010 Jan;64(1):47-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ambition and vision at student awards.
  • Eighty entries from students from schools of architecture and interior design all over the world were whittled down to just eight in the 2009 Architects for Health (AfH) Student Health Awards.
  • Jaime Bishop, a director of Fleet Architects, AfH executive board member, and the competition's organiser, describes the shortlisted and winning entries, discusses how candidates addressed the brief, and explains how the winner and two "runners-up" were chosen.
  • [MeSH-major] Awards and Prizes. Facility Design and Construction. Students
  • [MeSH-minor] Architecture as Topic. Great Britain

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21141718.001).
  • [Journal-full-title] Health estate
  • [ISO-abbreviation] Health Estate
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


5. Koletsa T, Hytiroglou P, Semoglou C, Drevelegas A, Karkavelas G: Angiomatoid fibrous histiocytoma with cystic structures of sweat duct origin. Pathol Int; 2007 Aug;57(8):513-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma with cystic structures of sweat duct origin.
  • Angiomatoid fibrous histiocytoma is an unusual soft tissue tumor, mostly arising in the subcutaneous fibro-adipose tissue of children and young adults and measuring a few centimeters in greatest dimension.
  • Reported herein is a unique case of angiomatoid fibrous histiocytoma containing epithelium-lined cystic structures.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / pathology. Neoplasms, Adnexal and Skin Appendage / pathology. Soft Tissue Neoplasms / pathology. Sweat Glands / pathology

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17610476.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


6. Kingman A, Albers JW, Arezzo JC, Garabrant DH, Michalek JE: Amalgam exposure and neurological function. Neurotoxicology; 2005 Mar;26(2):241-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Amalgam exposure and neurological function.
  • Concerns regarding the safety of silver-mercury amalgam fillings continue to be raised in the absence of any direct evidence of harm.
  • The widespread population exposure to amalgam mandated that a thorough investigation be conducted of its potential effects on the nervous system.
  • The National Institute of Dental and Craniofacial Research and U.S.
  • Air Force investigators collaborated in the ongoing Air Force Health Study (AFHS) of Vietnam era veterans.
  • The primary study question involved adverse health effects associated with exposure to herbicides or dioxin.
  • An assessment of exposure to dental amalgam fillings was added to the 1997-1998 health examination to investigate possible associations between amalgam exposure and neurological abnormalities.
  • Our study population consisted of 1663 dentate AFHS participants, comprised of 986 AFHS controls and 677 Ranch Hand veterans who were exposed to dioxin in Vietnam.
  • Two hundred and fifty-two of the participants had confirmed diabetes mellitus.
  • Study outcomes included clinical neurological signs, vibrotactile thresholds, and summary variables for different levels of peripheral neuropathy.
  • A limitation of our study is that our database did not include more sensitive continuous measures such as nerve conduction studies.
  • No significant associations were found between amalgam exposure and clinical neurological signs of abnormal tremor, coordination, station or gait, strength, sensation, or muscle stretch reflexes or for any level of peripheral neuropathy among our study participants.
  • A statistically significant association was detected between amalgam exposure and the continuous vibrotactile sensation response for the combined non-diabetic participants and separately for non-diabetic AFHS controls.
  • No significant association in this measure was detectable for non-diabetic Ranch Hand veterans or among the combined diabetic participants.
  • The association is a sub-clinical finding that was not associated with symptoms, clinically evident signs of neuropathy, or any functional impairment.
  • Overall, we found no association between amalgam exposure and neurological signs or clinically evident peripheral neuropathy.
  • Our findings do not support the hypothesis that exposure to amalgam produces adverse, clinically evident neurological effects.
  • [MeSH-major] Dental Amalgam / adverse effects. Peripheral Nervous System Diseases / chemically induced. Peripheral Nervous System Diseases / epidemiology. Veterans
  • [MeSH-minor] Diagnostic Techniques, Neurological. Humans. Male. Middle Aged. Multivariate Analysis. United States

  • MedlinePlus Health Information. consumer health - Peripheral Nerve Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15713345.001).
  • [ISSN] 0161-813X
  • [Journal-full-title] Neurotoxicology
  • [ISO-abbreviation] Neurotoxicology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 8049-85-2 / Dental Amalgam
  •  go-up   go-down


7. Romeo S, Dei Tos AP: Soft tissue tumors associated with EWSR1 translocation. Virchows Arch; 2010 Feb;456(2):219-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In fact, it is involved in a broad variety of mesenchymal lesions which includes Ewing's sarcoma/peripheral neuroectodermal tumor, desmoplastic small round cell tumor,clear cell sarcoma, angiomatoid fibrous histiocytoma, extraskeletal myxoid chondrosarcoma, and a subset of myxoid liposarcoma.

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1996 Feb;20(2):171-80 [8554106.001]
  • [Cites] Am J Surg Pathol. 2004 Oct;28(10 ):1379-83 [15371955.001]
  • [Cites] Oncogene. 1999 Sep 30;18(40):5506-13 [10523827.001]
  • [Cites] Am J Surg Pathol. 2007 Apr;31(4):576-84 [17414105.001]
  • [Cites] J Pathol. 2007 Sep;213(1):4-20 [17691072.001]
  • [Cites] Am J Surg Pathol. 1998 Nov;22(11):1303-13 [9808123.001]
  • [Cites] J Pathol. 1998 Sep;186(1):3-7 [9875133.001]
  • [Cites] Cell. 1997 Mar 7;88(5):593-602 [9054499.001]
  • [Cites] Virchows Arch. 2009 Apr;454(4):431-9 [19263077.001]
  • [Cites] Mod Pathol. 2004 Feb;17(2):214-21 [14657948.001]
  • [Cites] Am J Surg Pathol. 1992 Apr;16(4):411-6 [1314522.001]
  • [Cites] Am J Surg Pathol. 2001 Feb;25(2):133-46 [11176062.001]
  • [Cites] World J Gastroenterol. 2006 Oct 7;12 (37):6070-3 [17009412.001]
  • [Cites] J Biol Chem. 2000 Aug 11;275(32):24865-71 [10827180.001]
  • [Cites] J Clin Oncol. 1998 Sep;16(9):3028-36 [9738572.001]
  • [Cites] PLoS One. 2008 Jun 04;3(6):e2353 [18523561.001]
  • [Cites] Semin Cancer Biol. 2005 Jun;15(3):189-96 [15826833.001]
  • [Cites] J Biol Chem. 1998 Jul 17;273(29):18086-91 [9660765.001]
  • [Cites] Mol Cancer Ther. 2009 Feb;8(2):449-57 [19190116.001]
  • [Cites] Surg Oncol. 2008 Aug;17(2):107-12 [18191563.001]
  • [Cites] J Mol Biol. 2009 Feb 13;386(1):1-13 [19133275.001]
  • [Cites] Genes Chromosomes Cancer. 1992 Nov;5(4):271-7 [1283315.001]
  • [Cites] Clin Cancer Res. 2006 Sep 15;12 (18):5356-62 [17000668.001]
  • [Cites] Nat Genet. 1997 Nov;17(3):309-13 [9354795.001]
  • [Cites] Am J Surg Pathol. 1996 Jan;20(1):112-7 [8540602.001]
  • [Cites] Clin Cancer Res. 2009 Jun 15;15(12):4191-8 [19509155.001]
  • [Cites] Nucleic Acids Res. 1995 Mar 11;23(5):835-43 [7708500.001]
  • [Cites] Hum Pathol. 1997 Apr;28(4):502-9 [9104953.001]
  • [Cites] Nat Genet. 1997 Dec;17(4):495-7 [9398859.001]
  • [Cites] Eur J Cancer. 1995;31A(3):307-14 [7786593.001]
  • [Cites] J Pathol. 2009 Jan;217(1):83-93 [18855877.001]
  • [Cites] Am J Surg Pathol. 1997 Feb;21(2):219-25 [9042290.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Apr 15;166(2):173-9 [16631476.001]
  • [Cites] Int J Surg Pathol. 2003 Apr;11(2):75-81 [12754623.001]
  • [Cites] Mod Pathol. 2009 Jan;22(1):87-94 [18820660.001]
  • [Cites] Genomics. 1993 Dec;18(3):609-15 [8307570.001]
  • [Cites] Clin Cancer Res. 2009 Apr 1;15(7):2259-68 [19318479.001]
  • [Cites] Cancer. 1991 Nov 15;68(10):2251-9 [1655208.001]
  • [Cites] Cancer Cell. 2002 Nov;2(5):367-76 [12450792.001]
  • [Cites] Nat Med. 2009 Jul;15(7):750-6 [19584866.001]
  • [Cites] PLoS One. 2007 Oct 03;2(10):e979 [17912356.001]
  • [Cites] Blood. 1999 May 1;93(9):3088-95 [10216106.001]
  • [Cites] Am J Pathol. 2001 Jul;159(1):179-92 [11438465.001]
  • [Cites] Pigment Cell Melanoma Res. 2008 Aug;21(4):457-63 [18627530.001]
  • [Cites] Oncogene. 1996 Feb 1;12(3):489-94 [8637704.001]
  • [Cites] Clin Cancer Res. 2007 Dec 15;13(24):7322-8 [18094413.001]
  • [Cites] Br J Cancer. 2001 Feb;84(4):535-8 [11207050.001]
  • [Cites] Am J Surg Pathol. 1995 Jun;19(6):659-65 [7755152.001]
  • [Cites] Am J Pathol. 2000 Aug;157(2):377-84 [10934142.001]
  • [Cites] Am J Surg Pathol. 1999 Nov;23(11):1408-13 [10555010.001]
  • [Cites] J Mol Biol. 2006 Oct 13;363(1):27-38 [16965792.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Jul 15;120(2):91-8 [10942797.001]
  • [Cites] Blood. 1999 Feb 15;93(4):1355-63 [9949179.001]
  • [Cites] Semin Oncol. 2009 Aug;36(4):338-46 [19664494.001]
  • [Cites] Am J Surg Pathol. 1998 Nov;22(11):1314-27 [9808124.001]
  • [Cites] Cancer Res. 2008 Apr 1;68(7):2176-85 [18381423.001]
  • [Cites] Clin Mol Pathol. 1995 Apr;48(2):M79-82 [16695986.001]
  • [Cites] Cancer Res. 1998 Nov 15;58(22):5046-8 [9823307.001]
  • [Cites] J Pathol. 2008 May;215(1):78-86 [18338330.001]
  • [Cites] Cancer Res. 2004 May 15;64(10):3395-405 [15150091.001]
  • [Cites] J Clin Oncol. 2003 May 1;21(9):1775-81 [12721254.001]
  • [Cites] Am J Surg Pathol. 2007 Mar;31(3):454-9 [17325488.001]
  • [Cites] Nat Genet. 1998 Feb;18(2):184-7 [9462753.001]
  • [Cites] J Mol Diagn. 2007 Sep;9(4):459-63 [17620387.001]
  • [Cites] Cancer Res. 1995 Jan 1;55(1):24-7 [7805034.001]
  • [Cites] Lancet Oncol. 2007 Jul;8(7):595-602 [17586092.001]
  • [Cites] Cancer. 2001 Dec 1;92(11):2941-7 [11753970.001]
  • [Cites] Cancer Genet Cytogenet. 1988 Jan;30(1):145-50 [3422040.001]
  • [Cites] Hum Pathol. 2008 Dec;39(12):1763-70 [18703217.001]
  • [Cites] Mol Cell Biol. 2004 Aug;24(16):7275-83 [15282325.001]
  • [Cites] Mol Cell Biol. 1998 Mar;18(3):1489-97 [9488465.001]
  • [Cites] J Biol Chem. 1997 Dec 5;272(49):30822-7 [9388225.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2000 Mar;8(1):37-41 [10937047.001]
  • [Cites] J Biol Chem. 2001 Jun 22;276(25):22317-22 [11301318.001]
  • [Cites] Genomics. 1996 Oct 1;37(1):1-8 [8921363.001]
  • [Cites] Genes Chromosomes Cancer. 2002 Dec;35(4):340-52 [12378528.001]
  • [Cites] Nature. 1993 Jun 17;363(6430):640-4 [8510758.001]
  • [Cites] Oncogene. 2002 Mar 27;21(13):2009-19 [11960373.001]
  • [Cites] Cancer. 2000 Aug 15;89(4):793-9 [10951342.001]
  • [Cites] Oncogene. 1997 Oct 23;15(17):2069-75 [9366524.001]
  • [Cites] Oncogene. 2001 Jan 4;20(1):48-57 [11244503.001]
  • [Cites] J Mol Diagn. 2002 Feb;4(1):44-52 [11826187.001]
  • [Cites] Hum Pathol. 1999 Apr;30(4):430-5 [10208465.001]
  • [Cites] Am J Pathol. 1996 Apr;148(4):1125-38 [8644855.001]
  • [Cites] Cancer. 1996 Apr 15;77(8):1450-8 [8608528.001]
  • [Cites] Clin Cancer Res. 2001 Dec;7(12):3977-87 [11751490.001]
  • [Cites] Cancer Lett. 2007 Mar 8;247(1):84-90 [16730884.001]
  • [Cites] J Pathol. 2005 Aug;206(4):433-44 [15920699.001]
  • [Cites] Pediatr Blood Cancer. 2004 Jul;43(1):35-9 [15170887.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Dec;46(12):1051-60 [17724745.001]
  • [Cites] Hum Pathol. 1999 Aug;30(8):911-8 [10452503.001]
  • [Cites] Am J Surg Pathol. 1991 Jun;15(6):499-513 [1709557.001]
  • [Cites] Pathol Int. 2006 Sep;56(9):543-8 [16930335.001]
  • [Cites] Cancer Res. 2005 Dec 15;65(24):11459-68 [16357154.001]
  • [Cites] Cancer Cell. 2007 May;11(5):421-9 [17482132.001]
  • [Cites] Ann Surg Oncol. 2007 Apr;14(4):1507-14 [17252290.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Aug 24;213(3):1051-60 [7544579.001]
  • [Cites] J Clin Oncol. 1998 Apr;16(4):1248-55 [9552022.001]
  • [Cites] Gynecol Oncol. 2000 Oct;79(1):124-8 [11006044.001]
  • [Cites] Genomics. 1996 Nov 15;38(1):51-7 [8954779.001]
  • [Cites] Am J Pathol. 2006 May;168(5):1642-53 [16651630.001]
  • [Cites] Cancer Cell. 2002 May;1(4):393-401 [12086853.001]
  • [Cites] Nature. 1992 Sep 10;359(6391):162-5 [1522903.001]
  • [Cites] Cancer Res. 2003 Aug 1;63(15):4568-76 [12907633.001]
  • [Cites] J Clin Invest. 2007 May;117(5):1314-23 [17415412.001]
  • [Cites] Am J Surg Pathol. 1998 Mar;22(3):310-8 [9500772.001]
  • [Cites] Am J Surg Pathol. 2004 Jun;28(6):808-12 [15166674.001]
  • [Cites] Cancer. 1991 Apr 1;67(7):1886-93 [1848471.001]
  • [Cites] Nat Genet. 1993 Aug;4(4):341-5 [8401579.001]
  • [Cites] Semin Diagn Pathol. 2001 Nov;18(4):267-73 [11757867.001]
  • [Cites] EMBO J. 1996 Sep 16;15(18):5022-31 [8890175.001]
  • [Cites] Mod Pathol. 2002 Jun;15(6):673-8 [12065782.001]
  • [Cites] Cancer. 1979 Jun;43(6):2438-51 [222426.001]
  • [Cites] J Cancer Res Clin Oncol. 1993;119(3):172-8 [8418091.001]
  • (PMID = 19936782.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Calmodulin-Binding Proteins; 0 / EWSR1 protein, human; 0 / RNA-Binding Proteins
  • [Number-of-references] 124
  •  go-up   go-down


8. Gusack P: Is the sector just tilting at windmills? Health Estate; 2009 Jan;63(1):38-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is the sector just tilting at windmills?
  • Phil Gusack gives his personal slant on a recent Architects for Health (AfH) workshop on Sustainability in Hospitals and highlights the Department of Health's existing eco-achievements and the challenges it faces in enhancing the "green" credentials and environmental performance of its sizeable estate.
  • [MeSH-major] Conservation of Energy Resources / methods. Hospitals, Public
  • [MeSH-minor] Cost Control. Education. Government Agencies. Organizational Objectives. State Medicine

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19192598.001).
  • [Journal-full-title] Health estate
  • [ISO-abbreviation] Health Estate
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


9. Castelo PM, Pereira LJ, Bonjardim LR, Gavião MB: Changes in bite force, masticatory muscle thickness, and facial morphology between primary and mixed dentition in preschool children with normal occlusion. Ann Anat; 2010 Feb 20;192(1):23-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changes in bite force, masticatory muscle thickness, and facial morphology between primary and mixed dentition in preschool children with normal occlusion.
  • The study of stomatognathic system development can provide useful data for recognition of deviations from normality.
  • Thus, a longitudinal examination of 14 children with normal occlusion from primary (stage I, mean age 59.21+/-8.40 months) to early mixed dentition (stage II, 77.57+/-5.92) was performed.
  • Bite force was measured with a pressurized tube and correlated with ultrasonographic masseter and anterior portion of temporalis muscle thicknesses (at rest and maximal intercuspation), facial dimensions, age, and body mass index (BMI).
  • Facial dimensions were assessed by standardized frontal photographs as follows: anterior facial height (AFH), lower face height (LFH), and bizygomatic width (BFW).
  • Children with malocclusion, oral tissue/temporomandibular abnormalities, caries, or parafunctional habits were excluded.
  • Results were submitted to the Shapiro-Wilk test, t-test/Wilcoxon's test, and backward stepwise multiple regression (alpha=0.05) for analysis.
  • The results showed that muscle thickness did not differ significantly between the right and the left sides in either stage.
  • Bite force, AFH/BFW ratio, and masseter thickness at rest increased significantly from stage I to II, although temporalis thickness, LFH/AFH ratio, and BMI did not change between the stages.
  • The masseter thickness at rest and the stage of dentition were the most important factors contributing to bite force magnitude; the covariates age, BMI, and facial dimensions did not significantly influence bite force magnitude (power of the test: 96%).
  • In the studied sample, the increase in bite force observed from primary to early mixed dentition was explained by the increase in masseter thickness and the stage of dentition.
  • [MeSH-major] Bite Force. Dental Occlusion, Balanced. Dentition, Mixed. Face / anatomy & histology. Masticatory Muscles / anatomy & histology
  • [MeSH-minor] Body Mass Index. Child. Child, Preschool. Female. Humans. Male. Patient Selection. Stomatognathic System / anatomy & histology. Tooth, Deciduous. Zygoma / anatomy & histology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier GmbH. All rights reserved.
  • (PMID = 19914813.001).
  • [ISSN] 1618-0402
  • [Journal-full-title] Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft
  • [ISO-abbreviation] Ann. Anat.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


10. Matsumura T, Yamaguchi T, Tochigi N, Wada T, Yamashita T, Hasegawa T: Angiomatoid fibrous histiocytoma including cases with pleomorphic features analysed by fluorescence in situ hybridisation. J Clin Pathol; 2010 Feb;63(2):124-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma including cases with pleomorphic features analysed by fluorescence in situ hybridisation.
  • BACKGROUND: Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue tumour of uncertain differentiation and low metastatic potential.
  • [MeSH-major] Histiocytoma, Benign Fibrous / genetics. Soft Tissue Neoplasms / genetics

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20154033.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Calmodulin-Binding Proteins; 0 / EWSR1 protein, human; 0 / Neoplasm Proteins; 0 / RNA-Binding Protein FUS; 0 / RNA-Binding Proteins
  •  go-up   go-down


11. Guo H, Xiong Y, Nong L, Zhang S, Li T: [Reassessment of the pathological diagnosis in 33 cases of malignant fibrous histiocytoma]. Beijing Da Xue Xue Bao; 2008 Aug 18;40(4):374-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Reassessment of the pathological diagnosis in 33 cases of malignant fibrous histiocytoma].
  • OBJECTIVE: Since malignant fibrous histiocytoma (MFH) may be taken as an undifferentiated pleomorphic sarcoma (UPS), this study was conducted to reassess 33 previously diagnosed MFH cases in the past 10 years based on the latest WHO concept.
  • RESULTS: Among the 33 cases, 17 cases (51.5%) of MFH had their diagnoses changed, including 5 leiomyosarcomas, 3 malignant peripheral nerve sheath tumors, 1 fibrosarcoma, 1 inflammatory myofibrosarcoma, 1 giant cell tumor and 1 angiomatoid fibrous histiocytoma.
  • Eleven cases (68.8%) variously expressed CD68 (KP1) and 7 cases (43.8%) expressed CD68 (PG-M1), which were much higher than leiomyosarcoma, malignant peripheral nerve sheath tumor and liposarcoma with significant difference.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology

  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18677383.001).
  • [ISSN] 1671-167X
  • [Journal-full-title] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • [ISO-abbreviation] Beijing Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


12. Lemos MM, Karlen J, Tani E: Fine-needle aspiration cytology of angiomatoid malignant fibrous histiocytoma. Diagn Cytopathol; 2005 Aug;33(2):116-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine-needle aspiration cytology of angiomatoid malignant fibrous histiocytoma.
  • Angiomatoid malignant fibrous histiocytoma (AMFH) is a rare, low-grade malignant mesenchymal neoplasm that affects mostly the extremities of children and young adults.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Muscle Neoplasms / pathology

  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 16007669.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Flejsierowicz M, Ahmed MS, Kotov P, Cheng YC: Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report. WMJ; 2008 Jul;107(4):191-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
  • BACKGROUND: Multicentric Castleman's disease (MCD) in human immunodeficiency virus (HIV)-infected patients is an aggressive form of lymphoproliferative disorder that usually has a rapidly fatal outcome.
  • Overall mortality is 70%-85%, and median survival is only 8-14 months.
  • No standard or optimal therapy for MCD has been established.
  • CASE: A 49-year-old man with HIV infection presented with 1-week duration of low-grade fever, night sweats, left sided abdominal pain, and generalized weakness.
  • Physical examination revealed a supraclavicular, anterior cervical and axillary lymphadenopathy, and splenomegaly.
  • Excisional biopsy of the left axillary lymph node confirmed the diagnosis of an angiofollicular hyperplasia, or MCD, hyaline vascular type with CD20 positivity.
  • Treatment included a combination of the chemotherapy regimen of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) with the monoclonal anti-CD20 antibody rituximab.
  • The chemotherapy was administered in parallel with highly active antiretroviral therapy (HAART).
  • At a 3-year follow-up, the patient remains in complete remission and his HIV parameters have normalized with continued HAART.
  • CONCLUSION: This is the second publication describing the use of an aggressive combination of chemotherapy with rituximab in HIV-associated MCD.
  • For an HIV patient with MCD, an aggressive treatment with full CHOP regimen combined with monoclonal anti-CD20 antibody rituximab should be considered, and the use of HAART does not need to be discontinued.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Antiretroviral Therapy, Highly Active. Giant Lymph Node Hyperplasia / complications. Giant Lymph Node Hyperplasia / drug therapy. HIV Infections / complications. HIV Infections / drug therapy
  • [MeSH-minor] Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Murine-Derived. Cyclophosphamide / administration & dosage. Doxorubicin / administration & dosage. Humans. Male. Middle Aged. Prednisone / administration & dosage. Rituximab. Tomography, X-Ray Computed. Vincristine / administration & dosage


14. Castelo PM, Pereira LJ, Andrade AS, Marquezin MC, Gavião MB: Evaluation of facial asymmetry and masticatory muscle thickness in children with normal occlusion and functional posterior crossbite. Minerva Stomatol; 2010 Jul-Aug;59(7-8):423-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of facial asymmetry and masticatory muscle thickness in children with normal occlusion and functional posterior crossbite.
  • AIM: The aim of this study was to evaluate facial asymmetry and the thickness of the masticatory muscles in young children with normal occlusion and functional posterior crossbite.
  • METHODS: The sample comprised 72 children of both genders (64.71±7.04 months) in the primary and early mixed stage of dentition, divided into four groups: primary-normal occlusion (PriN; N=19), primary-crossbite (PriC; N=19), mixed-normal occlusion (MixN; N=27), and mixed-crossbite (MixC; N=16).
  • The thickness of the masseter and anterior portion of the temporalis muscle at rest and during maximal clenching were assessed by ultrasonography.
  • Facial morphology and asymmetry were evaluated by standardized front-view photographs, in which the following measurements were recorded: anterior face height (AFH), bizygomatic facial width (BFW), angle of the eye (AE) and angle of the mouth (AM) (interpupillary and commissure planes in relation to mid-sagittal plane, respectively).
  • RESULTS: The results showed that muscle thickness did not differ significantly between the sides of the dental arches in all groups (paired t-test).
  • Only the groups with normal occlusion presented significant positive correlation between AE and AM (Pearson's correlation test).
  • In PriN, only body weight was significantly related to masseter thickness; in MixN, facial morphology contributed significantly to masseter thickness at rest and maximal clenching, while the covariates weight, height and age did not relate to muscle thickness (stepwise backward multiple regression).
  • CONCLUSION: In the studied sample, children with crossbite presented greater facial asymmetry than those with normal occlusion, and a greater masseter thickness was related to larger faces in the mixed dentition.
  • [MeSH-major] Dental Occlusion. Facial Asymmetry / pathology. Malocclusion / pathology. Masticatory Muscles / pathology
  • [MeSH-minor] Body Weight. Cephalometry. Child. Cross-Sectional Studies. Dentition, Mixed. Female. Humans. Male. Masseter Muscle / pathology. Masseter Muscle / ultrasonography. Muscle Contraction. Organ Size. Photography. Reference Values. Temporal Muscle / pathology. Temporal Muscle / ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20842080.001).
  • [ISSN] 0026-4970
  • [Journal-full-title] Minerva stomatologica
  • [ISO-abbreviation] Minerva Stomatol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  •  go-up   go-down


15. Sutthiruangwong P, Thanakit V, Assavamongkolkul A: Angiomatoid fibrous histiocytoma with pain in a child. J Med Assoc Thai; 2005 Oct;88(10):1453-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma with pain in a child.
  • Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor with low-grade malignancy which occurs chiefly in children and young adults.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / complications. Pain / etiology. Soft Tissue Neoplasms / complications. Subcutaneous Tissue

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • MedlinePlus Health Information. consumer health - Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16519396.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


16. Demir M, Tekgündüz E, Edis M, Duran E, Kürüm T, Yiğitbaşı Ö, Yüksel M: Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients. Turk J Haematol; 2009 Dec 5;26(4):171-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients.
  • [Transliterated title] Medikal hastalarda anti-heparin trombosit faktör 4 antikor ve heparine bağlı trombositopeni sıklığı.
  • OBJECTIVE: Heparin-induced thrombocytopenia (HIT) is a life threatening complication of heparin therapy, causing thrombosis.
  • The aim of our study was to find out the frequencies of HIT antibody seroconversion and clinical HIT in Turkish medical patients on different forms of heparins.
  • METHODS: Our study included 61 patients who were on unfractionated heparin (UFH) (n: 37) and low molecular weight heparin (LMWH) (n: 24) therapies.
  • The frequency of HIT antibody formation was determined by means of antigenic (ELISA), and functional assays (serotonin release assay-SRA).
  • RESULTS: The seroconversion rates in UFH and LMWH groups were found to be 18.9% and 4.1% (ELISA), and 8.1% and 4.1% (SRA), respectively.
  • One patient (2.1%) on UFH therapy developed deep vein thrombosis.
  • No thromboembolic event was observed in patients taking LMWH.
  • CONCLUSION: Seroconversion rates by means of antigenic and functional assays and clinical HIT were more common in patients on UFH than patients on LMWH therapy.
  • Abstract available from the publisher.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27265628.001).
  • [ISSN] 1300-7777
  • [Journal-full-title] Turkish journal of haematology : official journal of Turkish Society of Haematology
  • [ISO-abbreviation] Turk J Haematol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


17. McCurry SM, LaFazia DM, Pike KC, Logsdon RG, Teri L: Managing sleep disturbances in adult family homes: recruitment and implementation of a behavioral treatment program. Geriatr Nurs; 2009 Jan-Feb;30(1):36-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Managing sleep disturbances in adult family homes: recruitment and implementation of a behavioral treatment program.
  • This article describes a sleep education program (SEP) designed to teach owner/operators and direct-care staff working in adult family homes (AFHs) how to improve the sleep and nighttime behavior of older residents with dementia.
  • There have been no sleep intervention studies conducted in AFHs, and strategies that are known to improve sleep in community-dwelling older adults or nursing home residents may not be feasible or effective in AFHs because of their unique care environment.
  • The SEP was developed on the basis of experiences treating sleep disturbances in community-dwelling older adults with dementia (the Nighttime Insomnia Treatment and Education in Alzheimer's Disease study).
  • In this article, we address both the clinical and empirical challenges faced by researchers recruiting and intervening in AFHs, raise issues pertinent to assessment of residents and staff, and discuss implications for evaluating the impact of behavioral treatments for sleep-wake disturbances in AFH residents.

  • MedlinePlus Health Information. consumer health - Sleep Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Sleep. 1991 Dec;14(6):540-5 [1798888.001]
  • [Cites] J Am Geriatr Soc. 2005 May;53(5):793-802 [15877554.001]
  • [Cites] Gerontologist. 2006 Feb;46(1):74-80 [16452286.001]
  • [Cites] Gerontologist. 2007 Jun;47(3):365-77 [17565101.001]
  • [Cites] J Am Geriatr Soc. 2007 Nov;55(11):1817-24 [17944896.001]
  • [Cites] J Gerontol Nurs. 2001 Sep;27(9):30-7 [11820554.001]
  • [Cites] Am Psychol. 1990 May;45(5):638-40 [2350081.001]
  • [Cites] Gerontologist. 2003 Aug;43(4):473-82 [12937326.001]
  • [Cites] Am J Alzheimers Dis Other Demen. 2003 Jul-Aug;18(4):240-6 [12955789.001]
  • [Cites] J Am Geriatr Soc. 2003 Oct;51(10):1455-60 [14511168.001]
  • [Cites] Sleep Med. 2004 Jul;5(4):373-7 [15222994.001]
  • [Cites] J Psychiatr Res. 1975 Nov;12(3):189-98 [1202204.001]
  • [Cites] Biol Psychiatry. 1988 Feb 1;23(3):271-84 [3337862.001]
  • [Cites] Med Clin North Am. 2002 May;86(3):641-56, viii [12168563.001]
  • (PMID = 19215811.001).
  • [ISSN] 1528-3984
  • [Journal-full-title] Geriatric nursing (New York, N.Y.)
  • [ISO-abbreviation] Geriatr Nurs
  • [Language] ENG
  • [Grant] United States / NIA NIH HHS / AG / AG005136-25; United States / NIMH NIH HHS / MH / R01 MH072736-03; United States / NIA NIH HHS / AG / P50 AG005136-25; United States / NIMH NIH HHS / MH / R01 MH072736; United States / NIA NIH HHS / AG / P50 AG005136; United States / NIMH NIH HHS / MH / MH072736-03; United States / NIMH NIH HHS / MH / R01-MH072736
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS57301; NLM/ PMC2643363
  •  go-up   go-down


18. Guihan M, Thomas MD, Mambourg FJ, Wang L, Chapko MK, Hedrick SC: Assisted living pilot program: background, methods, and facility characteristics. J Aging Health; 2009 Feb;21(1):172-89
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assisted living pilot program: background, methods, and facility characteristics.
  • Objectives. The Department of Veterans Affairs (VA) funded assisted living (AL), adult family home (AFH), and residential care for the first time in the Assisted Living Pilot Program (ALPP).
  • This article describes the background and methods of the ALPP evaluation and the characteristics and experiences of the facilities.
  • Method. Facility data were collected from the contracting/inspection process and a survey of ALPP facilities and those contacted but not participating in ALPP.
  • Results. Data on 131 participating facilities are presented: 41 AFHs, 47 assisted living facilities (ALFs), and 43 residential care facilities (RCFs).
  • The average facility had 33 beds (about one quarter Medicaid beds), for-profit ownership, and private rooms for ALPP residents, and about half had private baths.
  • About two thirds of ALPP AFH providers spoke a primary language other than English.
  • Discussion. Findings indicate that a wide range of community facilities were willing to provide care to residents with heterogeneous needs on VA funding.
  • [MeSH-major] Assisted Living Facilities. Homes for the Aged. Pilot Projects. Residence Characteristics. Residential Facilities. Veterans
  • [MeSH-minor] Adult. Aged. Female. Humans. Long-Term Care. Male. Middle Aged. Program Evaluation. United States. United States Department of Veterans Affairs

  • MedlinePlus Health Information. consumer health - Assisted Living.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19144974.001).
  • [ISSN] 0898-2643
  • [Journal-full-title] Journal of aging and health
  • [ISO-abbreviation] J Aging Health
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


19. Dandajena TC, Chung KW, Nanda RS: Assessment of anterior face height in a native African sample. Am J Orthod Dentofacial Orthop; 2006 Aug;130(2):196-201
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of anterior face height in a native African sample.
  • INTRODUCTION: The purpose of this research was to evaluate the anterior face height (AFH) of a native African ethnic group.
  • METHODS: Cephalograms of 101 adult ethnic Shona subjects (51 men, 50 women; age range, 18 to 38 years) were evaluated and compared with norms of African Americans and North American whites.
  • A number of measurements, some conventionally used and others specifically derived for this study, were assessed, including ANS to Me, Me to PP, and Me to FH, TAFH, NOrb, NANS, NPP, OrbANS, and OrbPP.
  • Three age groups were considered: less than 22 years, 22 to 25, and more than 25 years.
  • RESULTS: ANOVA detected significant differences among the 3 age groups and between the sexes.
  • AFH was higher in men than in women.
  • The post hoc Bonferroni test showed that NPP, NANS, and OrbPP were significantly different at ages less than 22 and more than 25.
  • The older age group had shorter heights than the younger group.
  • The AFH of the Shona was significantly lower than that of the African Americans.
  • All AFHs for the men and only TAFH for the women were significantly shorter for the Shona than for the whites.
  • CONCLUSIONS: The anterior vertical dimension of the Shona subjects was anatomically shorter than that of whites and African Americans, and conventional measurements did not provide the true status of the Shona, who had shorter lower AFHs.
  • [MeSH-major] African Continental Ancestry Group / statistics & numerical data. Face / anatomy & histology. Maxillofacial Development
  • [MeSH-minor] Adolescent. Adult. African Americans. Analysis of Variance. Cephalometry / statistics & numerical data. European Continental Ancestry Group. Female. Humans. Male. Open Bite / epidemiology. Sex Characteristics. Statistics, Nonparametric. Vertical Dimension. Zimbabwe / epidemiology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16905064.001).
  • [ISSN] 1097-6752
  • [Journal-full-title] American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics
  • [ISO-abbreviation] Am J Orthod Dentofacial Orthop
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Haque S, van Kirk R: Three patients with both Hodgkin's lymphoma and Castleman's disease: Clinicopathologic correlations and lack of association with HHV-8. Indian J Med Paediatr Oncol; 2009 Apr;30(2):76-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Three patients with both Hodgkin's lymphoma and Castleman's disease: Clinicopathologic correlations and lack of association with HHV-8.
  • BACKGROUND: The relationship between Hodgkin's lymphoma (HL) and plasma cell-type Castleman's disease (PCD) has been well documented.
  • There have been over 20 cases reported in the literature and nearly all of them were either diagnosed concurrently, or were initially diagnosed as PCD and upon review were found to have interfollicular HL.
  • Human herpes virus type 8 (HHV-8) is present in about 40% of cases with PCD.
  • It predisposes patients to a much higher risk of other malignancies, including Kaposi's sarcoma and non-Hodgkin's lymphoma.
  • Cases linked to HHV-8 are associated with a different morphology than cases that are not linked to HHV-8.
  • It has been proposed that patients with both HL and CD will have lymph nodes with HHV-8-negative morphology.
  • MATERIALS AND METHODS: We present a series of three cases in a retrospective study where patients had both HL and PCD.
  • Surgical pathology reports, clinical histories, and H and E and various immunohistochemical stains on initial work-up were examined and subsequent immunohistochemical stains for HHV-8 were obtained from the Methodist Hospital.
  • RESULTS: Patient 1 was diagnosed with PCD and interfollicular HL in the same lymph node.
  • Patient 2 was first diagnosed with classic HL and 2 years later returned with enlarged lymph nodes clinically suspected to be recurrent HL.
  • Histology showed angiofollicular hyperplasia and interfollicular plasmacytosis without Reed-Sternberg cells and a diagnosis of PCD was rendered.
  • Patient 3, a male in his third decade, was diagnosed with nodular sclerosing HL in the thymus, and concurrently PCD in the mediastinal lymph nodes.
  • All three cases had architectural features consistent with an HHV-8-negative morphology.
  • Immunohistochemical stains for HHV-8 were done retrospectively and were negative.
  • CONCLUSION: All three of our patients with both HL and CD had HHV-8-negative lymph node morphology and absence of HHV-8 by immunohistochemistry.
  • These patients, therefore, are not at an increased risk for the development of subsequent malignancies, when compared to HHV-8-positive patients.
  • Included in our series is one unique case where the diagnosis of HL preceded CD by 2 years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1991 Mar;18(3):249-53 [1675190.001]
  • [Cites] Am J Pathol. 1992 Jul;141(1):129-38 [1632458.001]
  • [Cites] Blood. 1991 Dec 1;78(11):2923-30 [1954381.001]
  • [Cites] Arch Pathol Lab Med. 1994 Mar;118(3):270-4 [8135630.001]
  • [Cites] Hum Pathol. 1993 Aug;24(8):833-9 [8375854.001]
  • [Cites] Arch Pathol Lab Med. 1996 Jan;120(1):91-6 [8554455.001]
  • [Cites] J Virol. 1997 Jan;71(1):839-42 [8985427.001]
  • [Cites] Head Neck. 2001 Feb;23(2):166-9 [11303634.001]
  • [Cites] J Clin Pathol. 2001 Oct;54(10):790-1 [11577129.001]
  • [Cites] Am J Hematol. 2002 Feb;69(2):119-26 [11835348.001]
  • [Cites] Cancer. 1956 Jul-Aug;9(4):822-30 [13356266.001]
  • [Cites] Am J Surg Pathol. 2003 Jan;27(1):91-100 [12502931.001]
  • [Cites] Histopathology. 2006 Feb;48(3):317-9 [16430484.001]
  • (PMID = 20596307.001).
  • [ISSN] 0975-2129
  • [Journal-full-title] Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
  • [ISO-abbreviation] Indian J Med Paediatr Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2885879
  • [Keywords] NOTNLM ; Castleman's disease / HHV-8 / Hodgkin's lymphoma / plasma cell variant of Castleman's disease
  •  go-up   go-down


21. Garbui IU, Nouer PR, Nouer DF, Magnani MB, Pereira Neto JS: Cephalometric assessment of vertical control in the treatment of class II malocclusion with a combined maxillary splint. Braz Oral Res; 2010 Jan-Mar;24(1):34-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cephalometric assessment of vertical control in the treatment of class II malocclusion with a combined maxillary splint.
  • Vertical control is one of the primary objectives sought by orthodontists when treating malocclusions in hyperdivergent individuals.
  • This investigation aimed at assessing vertical control, by cephalometric measurements, during the treatment of Angle Class II Division 1 malocclusion.
  • Thirty cases, selected from the files of the São Leopoldo Mandic Dental Research Center, Brazil, of subjects with Angle Class II Division 1 malocclusion and facial hyperdivergence, were used in this study.
  • The patients were treated using a combined extraoral appliance during a mean treatment time of 1.1 years.
  • Pre- and posttreatment cephalometric measurements were compared to assess vertical control.
  • The results were submitted to ANOVA (p = 5%).
  • The ANOVA test revealed no statistically significant difference between the pretreatment and posttreatment values of OP (Occlusal plane angle) and SN.MP.
  • While there was a decrease in Y-axis, FMA, and PP.MP, there was an increase in SN.PP, Co-Go, AFH, PFH, and FHI.
  • It was concluded that the divergence in the facial lower third of the patients did not increase, suggesting that the combined extraoral appliance with the line of force application directed to the resistance center of the maxilla was effective in treating Angle Class II malocclusion in hyperdivergent subjects.
  • [MeSH-major] Cephalometry. Extraoral Traction Appliances. Malocclusion, Angle Class II / therapy. Orthodontics, Corrective / methods
  • [MeSH-minor] Analysis of Variance. Female. Humans. Male. Maxilla / anatomy & histology. Maxillofacial Development. Occlusal Splints. Retrospective Studies. Sex Factors. Time Factors. Vertical Dimension

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20339711.001).
  • [ISSN] 1807-3107
  • [Journal-full-title] Brazilian oral research
  • [ISO-abbreviation] Braz Oral Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


22. Castelo PM, Gavião MB, Pereira LJ, Bonjardim LR: Maximal bite force, facial morphology and sucking habits in young children with functional posterior crossbite. J Appl Oral Sci; 2010 Mar-Apr;18(2):143-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maximal bite force, facial morphology and sucking habits in young children with functional posterior crossbite.
  • OBJECTIVE: The maintenance of normal conditions of the masticatory function is determinant for the correct growth and development of its structures.
  • Thus, the aims of this study were to evaluate the influence of sucking habits on the presence of crossbite and its relationship with maximal bite force, facial morphology and body variables in 67 children of both genders (3.5-7 years) with primary or early mixed dentition.
  • MATERIAL AND METHODS: The children were divided in four groups: primary-normocclusion (PN, n=19), primary-crossbite (PC, n=19), mixed-normocclusion (MN, n=13), and mixed-crossbite (MC, n=16).
  • Bite force was measured with a pressurized tube, and facial morphology was determined by standardized frontal photographs: AFH (anterior face height) and BFW (bizygomatic facial width).
  • RESULTS: It was observed that MC group showed lower bite force than MN, and AFH/BFW was significantly smaller in PN than PC (t-test).
  • Weight and height were only significantly correlated with bite force in PC group (Pearson's correlation test).
  • In the primary dentition, AFH/BFW and breast-feeding (at least six months) were positive and negatively associated with crossbite, respectively (multiple logistic regression).
  • In the mixed dentition, breast-feeding and bite force showed negative associations with crossbite (univariate regression), while nonnutritive sucking (up to 3 years) associated significantly with crossbite in all groups (multiple logistic regression).
  • CONCLUSIONS: In the studied sample, sucking habits played an important role in the etiology of crossbite, which was associated with lower bite force and long-face tendency.
  • [MeSH-major] Bite Force. Face / anatomy & histology. Fingersucking / adverse effects. Malocclusion / etiology. Sucking Behavior
  • [MeSH-minor] Child. Child, Preschool. Cross-Sectional Studies. Dental Stress Analysis. Female. Humans. Infant. Logistic Models. Male. Pacifiers / adverse effects. Statistics, Nonparametric

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Orthod Dentofacial Orthop. 1993 Apr;103(4):327-37 [8480698.001]
  • [Cites] Acta Odontol Scand. 1999 Apr;57(2):97-104 [10445363.001]
  • [Cites] Angle Orthod. 2007 Jul;77(4):607-11 [17605503.001]
  • [Cites] Eur J Orthod. 2001 Dec;23(6):741-9 [11890069.001]
  • [Cites] Braz Oral Res. 2008 Jan-Mar;22(1):48-54 [18425245.001]
  • [Cites] J Appl Oral Sci. 2006 Dec;14(6):448-53 [19089246.001]
  • [Cites] J Appl Oral Sci. 2004 Mar;12(1):39-44 [21365150.001]
  • [Cites] Am J Orthod Dentofacial Orthop. 2004 Jul;126(1):53-7 [15224059.001]
  • [Cites] Eur J Orthod. 1992 Jun;14(3):173-9 [1628683.001]
  • [Cites] Am J Orthod Dentofacial Orthop. 1995 Oct;108(4):389-93 [7572850.001]
  • [Cites] Angle Orthod. 1997;67(6):415-22; discussion 423-4 [9428959.001]
  • [Cites] Acta Odontol Scand. 1995 Jun;53(3):196-202 [7572097.001]
  • [Cites] Arch Oral Biol. 1996 Apr;41(4):323-32 [8771323.001]
  • [Cites] Int J Adult Orthodon Orthognath Surg. 1995;10(2):75-96 [9082002.001]
  • [Cites] Int J Paediatr Dent. 2004 May;14(3):155-66 [15139950.001]
  • [Cites] J Dent Res. 2002 Nov;81(11):752-6 [12407089.001]
  • [Cites] J Oral Rehabil. 2002 Dec;29(12):1174-80 [12472854.001]
  • [Cites] Am J Orthod Dentofacial Orthop. 2001 Nov;120(5):513-20 [11709670.001]
  • [Cites] Eur J Orthod. 2003 Jun;25(3):259-63 [12831215.001]
  • [Cites] Pediatr Dent. 2002 May-Jun;24(3):264-8 [12064503.001]
  • [Cites] Braz Oral Res. 2007 Jul-Sep;21(3):278-83 [17710296.001]
  • [Cites] Am J Orthod Dentofacial Orthop. 2009 Jul;136(1):52-8 [19577148.001]
  • [Cites] ASDC J Dent Child. 1991 May-Jun;58(3):253-5 [2066479.001]
  • [Cites] Eur J Orthod. 2005 Feb;27(1):53-7 [15743863.001]
  • [Cites] Angle Orthod. 2003 Oct;73(5):515-24 [14580018.001]
  • [Cites] Angle Orthod. 2001 Apr;71(2):116-9 [11302587.001]
  • [Cites] Early Hum Dev. 1995 Aug 18;42(3):185-93 [7493586.001]
  • [Cites] J Clin Pediatr Dent. 2003 Fall;28(1):75-9 [14604147.001]
  • [Cites] Eur J Orthod. 2008 Dec;30(6):580-5 [18775881.001]
  • [Cites] Eur J Orthod. 2004 Jun;26(3):237-44 [15222706.001]
  • (PMID = 20485925.001).
  • [ISSN] 1678-7765
  • [Journal-full-title] Journal of applied oral science : revista FOB
  • [ISO-abbreviation] J Appl Oral Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  •  go-up   go-down


23. Shao L, Singh V, Cooley L: Angiomatoid fibrous histiocytoma with t(2;22)(q33;q12.2) and EWSR1 gene rearrangement. Pediatr Dev Pathol; 2009 Mar-Apr;12(2):143-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma with t(2;22)(q33;q12.2) and EWSR1 gene rearrangement.
  • Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor of low malignant potential.
  • Histologically, the tumor forms lobulated sheets of plump round to spindle cells surrounded by a fibrous pseudocapsule and lymphoid cuff.
  • [MeSH-major] Calmodulin-Binding Proteins / genetics. Chromosomes, Human, Pair 2 / genetics. Chromosomes, Human, Pair 22 / genetics. Gene Rearrangement. Histiocytoma, Malignant Fibrous / genetics. RNA-Binding Proteins / genetics. Soft Tissue Neoplasms / genetics. Translocation, Genetic

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18666823.001).
  • [ISSN] 1093-5266
  • [Journal-full-title] Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
  • [ISO-abbreviation] Pediatr. Dev. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CREB1 protein, human; 0 / Calmodulin-Binding Proteins; 0 / Cyclic AMP Response Element-Binding Protein; 0 / EWSR1 protein, human; 0 / RNA-Binding Proteins
  •  go-up   go-down


24. Krawczun GA, Garcia Cde M, Ito K, Ferreira Filho OF, Thomson JC: Castleman's disease or angiofollicular hyperplasia as a solitary pulmonary nodule: case report. J Bras Pneumol; 2007 Mar-Apr;33(2):226-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Castleman's disease or angiofollicular hyperplasia as a solitary pulmonary nodule: case report.
  • Castleman's disease is a rare disorder generally characterized by a mediastinal nodule, with a great variety of alternative presentations regarding age, clinical manifestations and evolution.
  • This case report describes a 40-year-old female patient presenting with uncharacteristic chest pain for a few years.
  • A chest X-ray revealed a hypotransparency on the right side.
  • Computed tomography and pulmonary arteriography did not elucidate the diagnosis, which was made through surgical resection and anatomopathological examination of the nodule, which presented characteristics of angiofollicular hyperplasia, or Castleman's disease.
  • This article emphasizes the importance of adding this disease to the list of morbidities in the differential diagnosis of pulmonary solitary nodules.
  • [MeSH-major] Giant Lymph Node Hyperplasia / diagnosis. Solitary Pulmonary Nodule / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Mediastinum / pathology. Mediastinum / radiography. Mediastinum / surgery. Pulmonary Artery / radiography. Radiography, Thoracic. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Castleman's Disease.
  • Genetic Alliance. consumer health - Pulmonary Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17724544.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


25. Toutouzas K, Drakopoulou M, Dilaveris P, Vaina S, Gatzoulis K, Karabelas J, Riga M, Stefanadi E, Synetos A, Vlasis K, Stefanadis C: Inflammation in lone atrial fibrillation: new insights by coronary sinus thermography. Int J Cardiol; 2009 May 29;134(3):345-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammation in lone atrial fibrillation: new insights by coronary sinus thermography.
  • BACKGROUND: In the clinical setting there are conflicting results regarding the role of inflammatory activation in atrial fibrillation (AF).
  • Coronary sinus (CS) thermography assesses myocardial heat production and is correlated with inflammatory states.
  • We investigated in patients with AF whether 1) there is increased CS blood temperature and 2) the correlation of heat production with systemic inflammation.
  • METHODS: We included patients with AF and subjects with sinus rhythm.
  • C-reactive protein (CRP) levels were measured in all patients.
  • CS and right atrium (RA) blood temperature measurements were performed by a dedicated 7F thermography catheter.
  • DeltaT was calculated by subtracting RA from CS blood temperature.
  • RESULTS: We included 47 patients with AF and 23 subjects with sinus rhythm.
  • We stratified patients with AF into two groups: normotensive (AFN) and hypertensive (AFH).
  • DeltaT was lower in the RA compared with the CS in AFH (37.27+/-0.52 degrees C vs 37.47+/-0.54 degrees C, p<0.01), in AFN (37.13+/-0.53 degrees C vs 37.34+/-0.54 degrees C, p<0.01), and in controls (37.41+/-0.69 degrees C vs 37.55+/-0.68 degrees C, p<0.01).
  • DeltaTau was greater in AFH, and AFN compared to controls (0.20+/-0.07 degrees C, 0.20+/-0.08 degrees C, vs 0.14+/-0.06 degrees C, p<0.01).
  • DeltaT was similar between AFH and AFN (p=0.95).
  • CRP was higher in AFH and AFN compared to controls (1.72+/-0.85 mg/Dl, 1.69+/-0.94 mg/dL, 0.98+/-0.71 mg/dL, p<0.01).
  • CRP was similar between AFH and AFN (p=0.87).
  • A correlation between CRP with DeltaT was observed in AFH and AFN (R=0.58, p<0.01, R=0.44, p=0.02).
  • CONCLUSIONS: Patients with AF have increased myocardial heat production, which is correlated to the systemic inflammation.
  • CS blood temperature measurement may provide significant information for the pathogenesis of AF.
  • [MeSH-major] Atrial Fibrillation / pathology. Coronary Sinus / pathology. Myocarditis / pathology. Thermography / methods
  • [MeSH-minor] Aged. Body Temperature / physiology. Female. Humans. Inflammation / diagnosis. Inflammation / pathology. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Atrial Fibrillation.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18674828.001).
  • [ISSN] 1874-1754
  • [Journal-full-title] International journal of cardiology
  • [ISO-abbreviation] Int. J. Cardiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


26. Sharp C, Harkness M, Herbison P: Vertical changes in treated and untreated Class II division 1 malocclusions. Aust Orthod J; 2007 Nov;23(2):114-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vertical changes in treated and untreated Class II division 1 malocclusions.
  • BACKGROUND: Treatment-induced increases in the height of the face may be permanent.
  • AIMS: To determine if appliance-induced increases in the heights of the upper and lower molars in girls with Class II division 1 malocclusion, and the consequential increase in the height of the face are maintained.
  • METHODS: Ten angles and 10 distances were measured on lateral cephalometric radiographs of 11 year-old girls (Range: 8.5-14.8 years) with treated (N = 9) and untreated (N = 8) Class II division 1 malocclusions.
  • The intervals between the initial and recall records were, on average, 12 years (Range: 7.6-15.7 years) for the girls in the treatment group, and 8 years (Range: 4-13 years) for the girls in the untreated/control group.
  • In the treatment group eight girls were treated with the Begg appliance and Class II elastics.
  • RESULTS: Upper and lower molar dentoalveolar heights in both groups increased significantly between the initial and recall visits.
  • There were no significant differences between the molar heights in the groups at the start or at recall.
  • Anterior face height (AFH) also increased significantly in both groups between the initial and recall visits.
  • At recall, AFH in the treatment group was significantly greater than AFH in the control group.
  • This finding is attributed to a similar-sized difference between the groups at the start, to the longer period between the initial and recall records in the treatment group and to lesser variation in both groups at recall.
  • In both groups, posterior face height increased significantly between the initial and recall stages.
  • At the conclusion of the study there were no statistically significant differences between the treated and control groups in either overjet or the inclination of the upper incisors.
  • Relapse of the upper incisors in the treatment group and retroclination of the upper incisors in the control group reduced the initial differences between the groups.
  • These changes are attributed to altered lip posture and increased lip pressures in adolescence.
  • At recall, angles SNA and SNB were significantly smaller in the treatment group.
  • CONCLUSION: The heights of the upper and lower molars and the face increased in both groups.
  • Orthodontic treatment may have no lasting effects on either the height of the face or the heights of the molars in girls with Class II division 1 malocclusion.
  • [MeSH-major] Malocclusion, Angle Class II / therapy. Orthodontic Appliances / adverse effects. Orthodontics, Corrective / adverse effects. Vertical Dimension
  • [MeSH-minor] Adolescent. Case-Control Studies. Cephalometry. Child. Female. Humans. Molar / anatomy & histology. Molar / radiography. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18200789.001).
  • [ISSN] 0587-3908
  • [Journal-full-title] Australian orthodontic journal
  • [ISO-abbreviation] Aust Orthod J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


27. Dunham C, Hussong J, Seiff M, Pfeifer J, Perry A: Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes. Am J Surg Pathol; 2008 Mar;32(3):478-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes.
  • Angiomatoid fibrous histiocytoma (AFH) is generally considered a soft tissue sarcoma of low malignant potential that occurs in children/young adults and most frequently affects the extremities.
  • [MeSH-major] Brain Neoplasms / genetics. Chromosomes, Human, Pair 12. Chromosomes, Human, Pair 22. DNA-Binding Proteins / genetics. Gene Fusion. Histiocytoma, Malignant Fibrous / genetics. Nuclear Proteins / genetics. RNA-Binding Protein EWS / genetics. Translocation, Genetic

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18300800.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ATF1 protein, human; 0 / Activating Transcription Factor 1; 0 / DNA-Binding Proteins; 0 / Nuclear Proteins; 0 / RNA-Binding Protein EWS; 0 / Transcription Factors; 0 / regulatory factor X transcription factors
  •  go-up   go-down


28. Boyle SH, Jackson WG, Suarez EC: Hostility, anger, and depression predict increases in C3 over a 10-year period. Brain Behav Immun; 2007 Aug;21(6):816-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hostility, anger, and depression predict increases in C3 over a 10-year period.
  • We examined the relation of hostility, anger, and depression to 10-year changes in the third (C3), and fourth (C4) complement in 313, apparently healthy male participants enrolled in the Air Force Health Study (AFHS), a 20-year study designed to evaluate the health consequences of dioxin exposure.
  • Hostility, depression, and anger were assessed using subscales from the Minnesota Multiphasic Personality Inventory (MMPI), which was administered in 1985.
  • Given the high intercorrelations among these psychological scales, we used a principal component analysis to generate a composite score representing the linear combination of the hostility, anger, and depression scales.
  • The dependent variables, C3 and C4 levels, were determined from samples collected in 1992, 1997, and 2002.
  • Regression analyses controlling for age, race, alcohol use, body mass index, and cigarette use as well as onset of disease, and use of lipid lowering and blood pressure medications during follow-up revealed a significant timexcomposite score interaction for C3 complement (p<.0003), but not C4.
  • Post-hoc analyses revealed that high composite scores were associated with larger 10-year increases in C3.
  • These observations suggest that men who are hostile and are prone to experience frequent and intense feelings of anger, and depression show activation of the complement system, and specifically increases in C3, that may contribute to the development of coronary heart disease.

  • Genetic Alliance. consumer health - Depression.
  • MedlinePlus Health Information. consumer health - Depression.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabetes Care. 1993 Feb;16(2):445-9 [8432215.001]
  • [Cites] J Consult Psychol. 1948 May-Jun;12(3):164-70 [18867082.001]
  • [Cites] Acta Psychiatr Scand. 1989 Aug;80(2):142-7 [2801162.001]
  • [Cites] J Clin Invest. 1990 Mar;85(3):943-9 [2107212.001]
  • [Cites] Mol Immunol. 1990 Feb;27(2):197-201 [2157145.001]
  • [Cites] JAMA. 1990 Oct 10;264(14):1824-31 [2402041.001]
  • [Cites] J Clin Invest. 1993 Sep;92(3):1543-7 [8376604.001]
  • [Cites] J Affect Disord. 1994 Apr;30(4):283-8 [7516941.001]
  • [Cites] Am J Med. 1995 Apr;98(4):357-64 [7709948.001]
  • [Cites] Am J Epidemiol. 1995 Sep 1;142(5):477-84 [7677126.001]
  • [Cites] Circulation. 1996 Jun 1;93(11):1976-80 [8640971.001]
  • [Cites] Psychoneuroendocrinology. 1995;20(8):851-64 [8834092.001]
  • [Cites] N Engl J Med. 1997 Apr 10;336(15):1066-71 [9091804.001]
  • [Cites] Atherosclerosis. 1997 Mar 21;129(2):271-7 [9105570.001]
  • [Cites] Psychosom Med. 1997 Sep-Oct;59(5):481-7 [9316180.001]
  • [Cites] Psychoneuroendocrinology. 1997 Aug;22(6):397-409 [9364619.001]
  • [Cites] J Psychosom Res. 1997 Nov;43(5):529-34 [9394269.001]
  • [Cites] Psychosom Med. 1998 Jan-Feb;60(1):78-88 [9492244.001]
  • [Cites] J Psychosom Res. 1998 Feb;44(2):261-7 [9532555.001]
  • [Cites] Cardiologia. 1997 Dec;42(12):1245-50 [9534318.001]
  • [Cites] Int J Psychophysiol. 1998 Mar;28(2):157-66 [9545653.001]
  • [Cites] Psychosom Med. 1998 Nov-Dec;60(6):730-5 [9847033.001]
  • [Cites] J Immunol. 1999 Oct 1;163(7):3957-62 [10490997.001]
  • [Cites] Arch Intern Med. 2000 May 8;160(9):1261-8 [10809028.001]
  • [Cites] Lancet. 2000 May 6;355(9215):1621 [10821373.001]
  • [Cites] Diabetes Care. 2000 Jun;23(6):779-85 [10840996.001]
  • [Cites] Eur Heart J. 2000 Jul;21(13):1081-90 [10843826.001]
  • [Cites] Am J Cardiol. 2000 Jul 15;86(2):145-9 [10913473.001]
  • [Cites] Am J Pathol. 2001 Mar;158(3):1039-51 [11238052.001]
  • [Cites] Stroke. 2001 Jun;32(6):1443-8 [11387511.001]
  • [Cites] Psychol Aging. 2001 Jun;16(2):342-5 [11405320.001]
  • [Cites] Diabetes Care. 2002 May;25(5):835-9 [11978677.001]
  • [Cites] Psychol Methods. 2002 Jun;7(2):147-77 [12090408.001]
  • [Cites] Am J Cardiol. 2002 Dec 15;90(12):1279-83 [12480034.001]
  • [Cites] Brain Behav Immun. 2002 Dec;16(6):675-84 [12480498.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1920-5 [12578963.001]
  • [Cites] Psychosom Med. 2003 May-Jun;65(3):362-8 [12764208.001]
  • [Cites] Brain Behav Immun. 2003 Aug;17(4):296-303 [12831832.001]
  • [Cites] Psychosom Med. 2003 Jul-Aug;65(4):523-7 [12883100.001]
  • [Cites] Psychosom Med. 2003 Jul-Aug;65(4):582-7 [12883108.001]
  • [Cites] Brain Behav Immun. 2003 Oct;17(5):350-64 [12946657.001]
  • [Cites] Diabetes Care. 2004 Jan;27(1):129-33 [14693978.001]
  • [Cites] J Clin Lab Anal. 2004;18(1):1-8 [14730550.001]
  • [Cites] Psychosom Med. 2004 Sep-Oct;66(5):684-91 [15385692.001]
  • [Cites] Eur J Immunol. 1982 May;12(5):426-30 [7094993.001]
  • [Cites] Psychosom Med. 1989 Jan-Feb;51(1):46-57 [2928460.001]
  • [Cites] Clin Sci (Lond). 2005 Feb;108(2):129-35 [15487975.001]
  • [Cites] Diabetes. 2005 Feb;54(2):570-5 [15677517.001]
  • [Cites] J Interferon Cytokine Res. 2005 Jul;25(7):384-94 [16022583.001]
  • [Cites] Am J Cardiol. 2006 Jan 15;97(2):245-8 [16442371.001]
  • [Cites] Brain Behav Immun. 2006 Jul;20(4):331-8 [16288846.001]
  • [Cites] Brain Behav Immun. 2006 Jul;20(4):389-400 [16376518.001]
  • [Cites] Atherosclerosis. 2007 Jan;190(1):167-73 [16488421.001]
  • [Cites] Biol Psychiatry. 1989 Oct;26(6):640-2 [2790102.001]
  • (PMID = 17321106.001).
  • [ISSN] 0889-1591
  • [Journal-full-title] Brain, behavior, and immunity
  • [ISO-abbreviation] Brain Behav. Immun.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / HL067459-05; United States / NHLBI NIH HHS / HL / R01 HL067459; United States / NHLBI NIH HHS / HL / HL67459; United States / NHLBI NIH HHS / HL / R01 HL067459-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Complement C3; 0 / Complement C4
  • [Other-IDs] NLM/ NIHMS27496; NLM/ PMC1995457
  •  go-up   go-down


29. Ketchum NS, Michalek JE, Pavuk M: Mortality, length of life, and physical examination attendance in participants of the Air Force Health Study. Mil Med; 2007 Jan;172(1):53-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mortality, length of life, and physical examination attendance in participants of the Air Force Health Study.
  • Begun in 1982, the Air Force Health Study (AFHS) has assessed the mortality of veterans of Operation Ranch Hand, the unit responsible for aerially spraying herbicides in Vietnam.
  • A comparison group of other Air Force veterans involved with aircraft missions in Southeast Asia during the same period, but not involved with spraying herbicides, was included in the study.
  • Among 18,082 veterans, this report examined whether attendance at AFHS physical examinations from 1982 to 1999 played a role in mortality experience and potential lengthening of life relative to veterans who did not attend.
  • The years of potential life lost for 1173 veterans who died before age 65 was calculated.
  • No statistically significant difference in risk of death was found from all causes, cancer, or circulatory disease between attendees and nonattendees.
  • No evidence was found to suggest that attending physical examinations decreased mortality or substantially lengthened life in AFHS participants.
  • [MeSH-major] Life Expectancy / trends. Military Medicine. Military Personnel. Mortality / trends. Physical Examination / utilization. Veterans / statistics & numerical data. Vietnam Conflict
  • [MeSH-minor] Appointments and Schedules. Herbicides / supply & distribution. Herbicides / toxicity. Humans. Middle Aged. Risk Assessment. Texas. Vietnam

  • MedlinePlus Health Information. consumer health - Health Checkup.
  • MedlinePlus Health Information. consumer health - Veterans and Military Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17274267.001).
  • [ISSN] 0026-4075
  • [Journal-full-title] Military medicine
  • [ISO-abbreviation] Mil Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Herbicides
  •  go-up   go-down


30. Ajlan AM, Sayegh K, Powell T, David H, Riha RM, Khan J, Nahal A: Angiomatoid fibrous histiocytoma: magnetic resonance imaging appearance in 2 cases. J Comput Assist Tomogr; 2010 Sep-Oct;34(5):791-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma: magnetic resonance imaging appearance in 2 cases.
  • OBJECTIVE: Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor usually affecting the extremities of children and young adults and has a favorable prognosis.
  • CONCLUSIONS: Although the overall features of AFH can be confused with other subtypes of malignant fibrous histiocytoma, the young age at presentation, the location of the mass, the presence of intralesional blood-filled cystic spaces with fluid-fluid levels, associated features of hemosiderin deposition, and an enhancing fibrous pseudocapsule are all potential hints favoring this entity.
  • [MeSH-major] Histiocytoma, Benign Fibrous / diagnosis. Magnetic Resonance Imaging / methods. Soft Tissue Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20861788.001).
  • [ISSN] 1532-3145
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Kansara AH, Mehta SP: An exrathoracic presentation of castleman's disease. Indian J Otolaryngol Head Neck Surg; 2005 Apr;57(2):166-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An exrathoracic presentation of castleman's disease.
  • Castleman's disease, also known as angiofollicular hyperplasia, usually occurs in the mediastinum and rarely in cervical region as solitary mass.
  • Histopathologically four variants have been recognized (Castleman et al.
  • Cancer 1954;9:822-30) hyaline vascular type-most common type (Keller et al.
  • Cancer 1972;29:670-83) plasma cell type (Salisbury, Pediatric Pathol 1990;10:609-15) transitional type (Shahidi, Mayo Clinic Proc 1995;70:969-77) stromal rich type.
  • We report a case of Castleman's disease of typical histopathological picture of angio follicular hyperplasia arising from the right carotid triangle of neck in 12-year-old child without any associated systemic illness.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatr Pathol. 1990;10(4):609-15 [1695373.001]
  • [Cites] Cancer. 1956 Jul-Aug;9(4):822-30 [13356266.001]
  • [Cites] Mayo Clin Proc. 1995 Oct;70(10):969-77 [7564550.001]
  • [Cites] Cancer. 1972 Mar;29(3):670-83 [4551306.001]
  • (PMID = 23120165.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450978
  • [Keywords] NOTNLM ; Castlman's disease / angio follicular hyperplasia / neck
  •  go-up   go-down


32. Young CC, Ho MJ, Arun AB, Chen WM, Lai WA, Shen FT, Rekha PD, Yassin AF: Pseudoxanthomonas spadix sp. nov., isolated from oil-contaminated soil. Int J Syst Evol Microbiol; 2007 Aug;57(Pt 8):1823-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pseudoxanthomonas spadix sp. nov., isolated from oil-contaminated soil.
  • A bacterial isolate from a sample of oil-contaminated soil was characterized using a polyphasic taxonomic approach.
  • Comparative analysis of the 16S rRNA gene sequence showed that this isolate constituted a distinct phyletic line within the genus Pseudoxanthomonas, displaying >3.7 % sequence divergence with respect to recognised Pseudoxanthomonas species.
  • The genus assignment was confirmed by a chemotaxonomic analysis, which revealed the presence of a fatty acid profile characteristic of members of the genus Pseudoxanthomonas (straight-chain saturated, unsaturated and branched-chain fatty acids of the iso/anteiso type and 3-hydroxylated fatty acids) and the presence of a ubiquinone with eight isoprene units (Q-8) as the predominant respiratory quinone.
  • The novel isolate was distinguishable from other members of the genus Pseudoxanthomonas on the basis of a combination of phenotypic properties.
  • The genotypic and phenotypic data show that the strain represents a novel species of the genus Pseudoxanthomonas, for which the name Pseudoxanthomonas spadix sp. nov. is proposed.
  • The type strain is IMMIB AFH-5(T) (=DSM 18855(T)=CCUG 53828(T)).
  • [MeSH-major] Soil Microbiology. Xanthomonadaceae / classification. Xanthomonadaceae / isolation & purification
  • [MeSH-minor] DNA, Bacterial / genetics. DNA, Ribosomal / genetics. Fatty Acids / analysis. Molecular Sequence Data. Petroleum / metabolism. Phylogeny. RNA, Ribosomal, 16S / genetics

  • SILVA. SILVA SSU Database .
  • StrainInfo. culture/stock collections - online strain list (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17684265.001).
  • [ISSN] 1466-5026
  • [Journal-full-title] International journal of systematic and evolutionary microbiology
  • [ISO-abbreviation] Int. J. Syst. Evol. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AM418384
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Bacterial; 0 / DNA, Ribosomal; 0 / Fatty Acids; 0 / Petroleum; 0 / RNA, Ribosomal, 16S
  •  go-up   go-down


33. Dong QM, He YJ: [Analysis of twelve cases of angiofollicular lymph node hyperplasia with literature review]. Ai Zheng; 2008 Jan;27(1):101-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of twelve cases of angiofollicular lymph node hyperplasia with literature review].
  • BACKGROUND & OBJECTIVE: Angiofollicular lymph node hyperplasia (AFH) is a rare lymphoproliferative disorder disease.
  • This study was to investigate the clinical characteristics, treatment and prognosis of AFH.
  • METHODS: Clinical data of 12 AFH patients, admitted in Guangdong Provincial People's Hospital from Oct.
  • 1989 to Dec. 2006, were analyzed.
  • All cases were diagnosed by lymph node biopsy.
  • RESULTS: Of the 12 cases of AFH, 9 were unicentric disease characterized by localized lymph node enlargement, and 3 were multicentric disease characterized by multiple lymph node enlargement accompanied by systemic symptoms.
  • The 9 patients with unicentric disease received tumor resection and were followed up for a median of 30 months; 8 responded well to surgical resection and 1 was lost.
  • Of the 3 patients with multicentric disease, 2 were treated with chemotherapy and achieved partial remission, 1 received no antitumor therapy and died of multi-organ failure in 21 months.
  • CONCLUSION: Unicentric AFH can be cured by surgery alone and have a good prognosis after operation; multicentric AFH needs aggressive and systemic chemotherapy.
  • [MeSH-major] Giant Lymph Node Hyperplasia / surgery
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cyclophosphamide / therapeutic use. Disease-Free Survival. Doxorubicin / therapeutic use. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prednisone / therapeutic use. Vincristine / therapeutic use. Young Adult

  • Genetic Alliance. consumer health - Angiofollicular Lymph Hyperplasia.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18184475.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  • [Number-of-references] 12
  •  go-up   go-down


34. López Montes A, Andrés Mompeán E, Martínez Villaescusa M, Llamas Fuente F, García-Mauriño Guelbenzu ML: [Acute renal failure due to thrombotic microangiopathy associated with Castleman's disease]. An Med Interna; 2007 Dec;24(12):591-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acute renal failure due to thrombotic microangiopathy associated with Castleman's disease].
  • [Transliterated title] Fracaso renal agudo por microangiopatía trombótica asociado a enfermedad de Castleman.
  • We report a case of a 30-year-old man presenting with abdominal pain, fever, homodynamic instability, hepatosplenomegaly, acute renal failure, cervical lymph nodes, anaemia and thrombocytopenia.
  • The patient was treated with empiric antibiotics, high dose corticosteroids, gammaglobulins, noradrenalin and diary intermittent haemodialysis, with an excellent response.
  • The renal biopsy showed a thrombotic microangiopathy, the lymph node biopsy showed a Castleman s disease.
  • Castleman s disease (also known as giant lymph node hyperplasia or angiofollicular lymph node hyperplasia) is a clinicopathological entity of unknown aetiology.
  • A number of renal alterations have been described in association with the Castleman s disease.
  • [MeSH-major] Acute Kidney Injury / etiology. Giant Lymph Node Hyperplasia / complications. Thrombosis / complications
  • [MeSH-minor] Adult. Humans. Male

  • Genetic Alliance. consumer health - Castleman's Disease.
  • MedlinePlus Health Information. consumer health - Blood Clots.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18278998.001).
  • [ISSN] 0212-7199
  • [Journal-full-title] Anales de medicina interna (Madrid, Spain : 1984)
  • [ISO-abbreviation] An Med Interna
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


35. Black RN, Bell PM: Comment on: Weickert MO, Pfeiffer AFH (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49:1732-1741. Diabetologia; 2007 Feb;50(2):493-4; author reply 495-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comment on: Weickert MO, Pfeiffer AFH (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49:1732-1741.
  • [MeSH-major] Glucose / metabolism. Liver / metabolism. Signal Transduction / physiology
  • [MeSH-minor] Fatty Liver / metabolism. Humans. Lipids / physiology

  • Hazardous Substances Data Bank. GLUCOSE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Diabetologia. 2006 Aug;49(8):1732-41 [16718463.001]
  • [Cites] Atherosclerosis. 2003 Jan;166(1):151-61 [12482562.001]
  • [Cites] Metabolism. 1995 Feb;44(2):212-7 [7869918.001]
  • [Cites] Diabetologia. 2006 Aug;49(8):1732-41 [16718463.001]
  • [Cites] Nutr Metab Cardiovasc Dis. 2000 Feb;10(1):1-6 [10812581.001]
  • [Cites] J Biol Chem. 2000 Jun 2;275(22):16638-42 [10828060.001]
  • [Cites] Diabetes Care. 1988 Jun;11(6):495-9 [3042317.001]
  • [Cites] Diabetologia. 1993 Feb;36(2):161-9 [8458531.001]
  • [Cites] Eur J Clin Invest. 2001 Jul;31(7):603-9 [11454015.001]
  • [Cites] Diabet Med. 1995 Mar;12(3):250-7 [7758262.001]
  • [Cites] Atherosclerosis. 1999 Sep;146(1):195-6 [10487504.001]
  • (PMID = 17149588.001).
  • [ISSN] 0012-186X
  • [Journal-full-title] Diabetologia
  • [ISO-abbreviation] Diabetologia
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Lipids; IY9XDZ35W2 / Glucose
  •  go-up   go-down


36. Whitnall MH, Villa V, Seed TM, Benjack J, Miner V, Lewbart ML, Dowding CA, Jackson WE 3rd: Molecular specificity of 5-androstenediol as a systemic radioprotectant in mice. Immunopharmacol Immunotoxicol; 2005;27(1):15-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular specificity of 5-androstenediol as a systemic radioprotectant in mice.
  • We compared in vivo radioprotective efficacy of 5-androstenediol (5-AED) to that of ten other steroids: 17alpha-androstenediol, dehydroepiandrosterone, 5-androstenetriol (AET), 4-androstenedione (AND), testosterone, estradiol, fluasterone, 16alpha-bromoepiandrosterone, 16alpha-fluoro-androst-5-en-17alpha-ol (alpha-fluorohydrin, AFH), and 16alpha-fluoro-androst-5-en-17beta-ol (beta-fluorohydrin).
  • Steroids were administered 24 or 48 hr before, or 1 hr after, whole-body gamma-irradiation.
  • Two days after irradiation at 3 Gy, blood elements were counted.
  • In addition, after irradiation at 9-12.5 Gy, survival was recorded for 30 days.
  • The results showed radioprotective efficacy was specific for 5-AED.
  • One other steroid, AFH, demonstrated appreciable survival effects but was less efficacious than 5-AED.
  • AND and AET produced slight enhancement of survival in some experiments.
  • This is the first demonstration that the prophylactic window for survival enhancement by 1 subcutaneous (s.c.) injection of 5-AED is as long as 48 hr in mice.
  • Moreover, the results indicate that 1 s.c. injection of 5-AED 1 hr after irradiation is much less effective than 1 injection 24-48 hr before irradiation.
  • Comparing the molecular features of steroids with radioprotective efficacy leads to the following conclusions:.
  • 1) these effects are due to interaction with specific receptors, since s.c. injection of extremely similar molecules with the same physicochemical properties as 5-AED were not radioprotective;.
  • 2) the 17-hydroxyl group is essential;.
  • 3) this group must be in the beta configuration in the absence of nearby side groups;.
  • 4) a halogen atom at 16 changes the 17-hydroxyl specificity to alpha;.
  • 5) the 3beta-hydroxyl group is not essential;.
  • 6) addition of a 7beta-hydroxyl group is deleterious; and 7) the effects are not due to activation of sex steroid receptors.
  • [MeSH-major] Androstenediol / pharmacology. Radiation-Protective Agents / pharmacology
  • [MeSH-minor] Animals. Female. Gamma Rays / adverse effects. Leukocyte Count. Male. Mice. Mice, Inbred C3H. Mice, Inbred C57BL. Mice, Inbred DBA. Neutrophils / drug effects. Neutrophils / radiation effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15803857.001).
  • [ISSN] 0892-3973
  • [Journal-full-title] Immunopharmacology and immunotoxicology
  • [ISO-abbreviation] Immunopharmacol Immunotoxicol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiation-Protective Agents; 95PS51EMXY / Androstenediol
  •  go-up   go-down


37. Thway K: Angiomatoid fibrous histiocytoma: a review with recent genetic findings. Arch Pathol Lab Med; 2008 Feb;132(2):273-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma: a review with recent genetic findings.
  • Angiomatoid fibrous histiocytoma is a neoplasm of intermediate biologic potential most often arising in the extremities of children and young adults.
  • Originally described as a type of malignant fibrous histiocytoma, its differentiation remains enigmatic, with precise histogenesis still only hypothesized.
  • The literature on angiomatoid fibrous histiocytoma is reviewed, particularly with regard to recent molecular genetic developments and differentiation, and its morphology, immunohistochemistry, and differential diagnosis are summarized.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / genetics. Soft Tissue Neoplasms / genetics. Translocation, Genetic / genetics

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • Genetics Home Reference. consumer health - chromosome 12.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18251589.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Desmin
  • [Number-of-references] 27
  •  go-up   go-down


38. Pratibha R, Ahmed S: Angiomatoid variant of fibrous histiocytoma: a case report and review of literature. Int J Paediatr Dent; 2006 Sep;16(5):363-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid variant of fibrous histiocytoma: a case report and review of literature.
  • Fibrous histiocytomas by themselves are not very common in the head and neck region.
  • Apart from considering the above fact, this report describes a unique and relatively rare variant of the neoplasm - the angiomatoid fibrous histiocytoma (AFH) which has a characteristic appearance and predilection for young individuals that occurred in the left lower border of the mandible in a 13-year-old girl.
  • Angiomatoid fibrous histiocytoma is a distinct fibrohistiocytic tumour of children and young adults that combines features of both fibrohistiocytic and vascular neoplasm.
  • It is considered to be a tumour of intermediate malignancy because of its less aggressive course in contrast to the conventional malignant fibrous histiocytoma.

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16879335.001).
  • [ISSN] 0960-7439
  • [Journal-full-title] International journal of paediatric dentistry
  • [ISO-abbreviation] Int J Paediatr Dent
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 35
  •  go-up   go-down


39. Sabah M, Cummins R, Leader M, Kay E: Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p. Virchows Arch; 2005 Mar;446(3):251-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p.
  • The specimens consisted of 17 cases of soft tissue leiomyosarcoma (LMS), 4 cases of cutaneous LMS, 22 cases of conventional malignant fibrous histiocytoma (MFH) and 2 cases of angiomatoid fibrous histiocytoma.
  • The frequency of allelic imbalance at different loci on chromosome 9p was analysed in LMS and MFH and then compared with values previously examined in synovial sarcoma and malignant peripheral nerve sheath tumour.
  • Alterations of this locus were very rare in synovial sarcoma and malignant peripheral nerve sheath tumours and were absent in cutaneous LMS and angiomatoid fibrous histiocytoma.
  • [MeSH-major] Chromosomes, Human, Pair 9 / genetics. DNA, Neoplasm / genetics. Histiocytoma, Benign Fibrous / genetics. Leiomyosarcoma / genetics. Soft Tissue Neoplasms / genetics

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lab Invest. 2001 Feb;81(2):211-5 [11232643.001]
  • [Cites] Arch Pathol Lab Med. 1994 Feb;118(2):160-4 [8311656.001]
  • [Cites] Semin Diagn Pathol. 1995 Aug;12(3):210-20 [8545588.001]
  • [Cites] Arch Pathol Lab Med. 1988 Mar;112(3):236-7 [2830862.001]
  • [Cites] Nature. 1996 Mar 14;380(6570):152-4 [8600387.001]
  • [Cites] Cancer. 1972 Jun;29(6):1518-29 [5031245.001]
  • [Cites] Mod Pathol. 2004 Nov;17(11):1364-71 [15181453.001]
  • [Cites] Am J Surg Pathol. 1992 Mar;16(3):213-28 [1317996.001]
  • [Cites] Br J Cancer. 2003 Feb 24;88(4):510-5 [12592363.001]
  • [Cites] Hum Pathol. 1999 Nov;30(11):1336-43 [10571514.001]
  • [Cites] Nature. 1994 Sep 15;371(6494):257-61 [8078588.001]
  • [Cites] Nature. 1994 Apr 21;368(6473):753-6 [8152487.001]
  • [Cites] Histopathology. 1987 Apr;11(4):433-7 [3036682.001]
  • [Cites] J Pathol. 2000 Dec;192(4):502-10 [11113868.001]
  • [Cites] Am J Surg Pathol. 1990 Dec;14(12):1126-32 [2174650.001]
  • [Cites] Int J Cancer. 1984 Jan 15;33(1):37-42 [6693192.001]
  • [Cites] Pathol Int. 2003 Mar;53(3):163-8 [12608897.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):704-7 [8259215.001]
  • [Cites] Histopathology. 1995 Dec;27(6):525-32 [8838332.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Apr 15;118(2):89-98 [10748288.001]
  • [Cites] J Clin Pathol. 2003 Sep;56(9):666-71 [12944549.001]
  • [Cites] Pathol Res Pract. 1996 Aug;192(8):877-81 [8897524.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):97-102 [16540739.001]
  • [Cites] Genes Chromosomes Cancer. 2000 Feb;27(2):191-5 [10612808.001]
  • [Cites] Science. 1994 Apr 15;264(5157):436-40 [8153634.001]
  • (PMID = 15731925.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


40. Mukiibi M, Ela WP, Sáez AE: Effect of ferrous iron on arsenate sorption to amorphous ferric hydroxide. Ann N Y Acad Sci; 2008 Oct;1140:335-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of ferrous iron on arsenate sorption to amorphous ferric hydroxide.
  • Amorphous ferric hydroxide (AFH) sorbents are commonly used for removal of arsenate from water.
  • When disposed in microbially active, reducing environments, such as landfills, Fe(II) will be generated by reductive dissolution of the AFH surface and arsenate will be desorbed.
  • However, the observed ratio of arsenate (and, in fact, total arsenic) to total iron in the leachate is not consistent with the original ratio of arsenate to iron on the AFH.
  • Work to determine if ferrous iron re-adsorption to the AFH can partially explain this inconsistency is described.
  • As pH increases above 7, Fe(II) increasingly sorbs onto the AFH surface.
  • This sorption is largely independent of ionic strength and somewhat irreversible at high pH.
  • In contrast, arsenate partitioning to AFH decreases with increasing pH.
  • However, over the pH range from 5 to 9, the presence of Fe(II) sorbed to the AFH surface increases the capacity for arsenate sorption.
  • In addition, when no Fe(II) is present, arsenate binding is largely to surface sites inaccessible to Fe(II) binding.
  • The results are also consistent with Fe(II) sorption to AFH sites, otherwise unfavorable to arsenate binding and transformation of those sites into arsenate-amenable binding sites.
  • [MeSH-major] Arsenates / chemistry. Arsenic / analysis. Chemistry Techniques, Analytical / instrumentation. Ferric Compounds / chemistry. Iron / pharmacology
  • [MeSH-minor] Adsorption. Arsenites / chemistry. Hydrogen-Ion Concentration. Ions. Water / chemistry. Water Purification

  • MedlinePlus Health Information. consumer health - Arsenic.
  • MedlinePlus Health Information. consumer health - Iron.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • Hazardous Substances Data Bank. ARSENIC, ELEMENTAL .
  • Hazardous Substances Data Bank. Water .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18991933.001).
  • [ISSN] 1749-6632
  • [Journal-full-title] Annals of the New York Academy of Sciences
  • [ISO-abbreviation] Ann. N. Y. Acad. Sci.
  • [Language] eng
  • [Grant] United States / NIEHS NIH HHS / ES / P42 ES04940
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Arsenates; 0 / Arsenites; 0 / Ferric Compounds; 0 / Ions; 059QF0KO0R / Water; 2UA751211N / ferric hydroxide; E1UOL152H7 / Iron; N712M78A8G / Arsenic
  •  go-up   go-down


41. Shin JW, Park HS, Kim BK, Kim YA, Kim MG, Won CH, Cho S: Aneurysmal benign fibrous histiocytoma with atrophic features. Ann Dermatol; 2009 Feb;21(1):42-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aneurysmal benign fibrous histiocytoma with atrophic features.
  • Aneurysmal benign fibrous histiocytoma is an uncommon pathologic variant of dermatofibroma.
  • It should be differentiated from angiomatoid malignant fibrous histiocytoma, malignant melanoma, and vascular tumors such as Kaposi's sarcoma and angiosarcoma.
  • We report a case of aneurysmal benign fibrous histiocytoma with atrophic features in a 27-year-old male who had a grayish-brown atrophic patchy lesion on his back for 2 years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Dermatol. 1991 Dec;25(6 Pt 1):1081-2 [1810988.001]
  • [Cites] J Am Acad Dermatol. 1987 Dec;17(6):947-50 [3429722.001]
  • [Cites] Cancer. 1981 Apr 15;47(8):2053-61 [6261935.001]
  • [Cites] Histopathology. 1995 Jun;26(6):519-27 [7545142.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2006 Mar;20(3):331-3 [16503899.001]
  • [Cites] Am J Dermatopathol. 1997 Apr;19(2):147-53 [9129699.001]
  • [Cites] J Cutan Pathol. 2000 Jul;27(6):312-5 [10885409.001]
  • [Cites] Histopathology. 1995 Apr;26(4):323-31 [7607620.001]
  • [Cites] J Clin Pathol. 1996 Apr;49(4):313-8 [8655708.001]
  • (PMID = 20548854.001).
  • [ISSN] 2005-3894
  • [Journal-full-title] Annals of dermatology
  • [ISO-abbreviation] Ann Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2883367
  • [Keywords] NOTNLM ; Aneurysmal variant / Atrophy / Dermatofibroma
  •  go-up   go-down


42. Azarpira N, Ashraf MJ, Shishegar M: Fine needle aspiration findings in angiofollicular hyperplasia with eosinophilia: a case report. Acta Cytol; 2008 Mar-Apr;52(2):220-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSION: Various conditions, both benign and malignant, may mimic Kimura's disease clinically and on smears.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18499999.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Bherwani AK, Fida M: Morphological characteristics affecting extraction decision in class ii division 1 malocclusion in females. J Coll Physicians Surg Pak; 2007 Aug;17(8):486-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Morphological characteristics affecting extraction decision in class ii division 1 malocclusion in females.
  • OBJECTIVE: To determine the morphological characteristics affecting extraction decision in Class II Division 1 malocclusion in females.
  • DESIGN: Cross-sectional study.
  • PLACE AND DURATION OF STUDY: Dental Section, The Aga Khan University Hospital, Karachi, from June 2002 to June 2004.
  • PATIENTS AND METHODS: Lateral cephalograms and study casts of 35 female patients having Class II Division 1 malocclusion were taken.
  • Out of those, 13 were treated with 4 premolar extractions while 22 were treated on non-extraction basis.
  • The cephalometric and cast analysis of Aga Khan University Hospital was used.
  • RESULTS: Patients in the extraction group had larger SN-MP, FMA, and LFH: AFH, L1-NB (mm), E plane-LS, E plane-LI, S line-LS, S line-LI, and smaller Z angle.
  • However, the sagittal discrepancy and tooth size arch length discrepancy had no significant difference between the two groups.
  • CONCLUSION: The vertical dimensions and the upper and lower lip were the key structures to decide about extraction or non-extraction.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17785128.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


44. Hallor KH, Micci F, Meis-Kindblom JM, Kindblom LG, Bacchini P, Mandahl N, Mertens F, Panagopoulos I: Fusion genes in angiomatoid fibrous histiocytoma. Cancer Lett; 2007 Jun 18;251(1):158-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fusion genes in angiomatoid fibrous histiocytoma.
  • Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor of low malignant potential and uncertain differentiation.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / pathology. Oncogene Proteins, Fusion / genetics

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17188428.001).
  • [ISSN] 0304-3835
  • [Journal-full-title] Cancer letters
  • [ISO-abbreviation] Cancer Lett.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / ATF1 protein, human; 0 / Activating Transcription Factor 1; 0 / Calmodulin-Binding Proteins; 0 / DNA-Binding Proteins; 0 / EWSR1 protein, human; 0 / Nuclear Proteins; 0 / Oncogene Proteins, Fusion; 0 / RNA-Binding Protein FUS; 0 / RNA-Binding Proteins; 0 / Transcription Factors; 0 / regulatory factor X transcription factors
  •  go-up   go-down


45. Mangham DC, Williams A, Lalam RK, Brundler MA, Leahy MG, Cool WP: Angiomatoid fibrous histiocytoma of bone: a calcifying sclerosing variant mimicking osteosarcoma. Am J Surg Pathol; 2010 Feb;34(2):279-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma of bone: a calcifying sclerosing variant mimicking osteosarcoma.
  • Angiomatoid fibrous histiocytoma is a neoplasm of uncertain histogenesis, which most commonly arises in the subcutaneous tissue of the extremities of children and young adults.
  • This case arose in bone-a site where there has been just 1 previously published case of typical (nonsclerosing/mineralizing) angiomatoid fibrous histiocytoma.
  • Due to the rarity of angiomatoid fibrous histiocytoma at this site and the presence of matrical sclerosis/mineralization, this case raised the important differential diagnosis of osteosarcoma, both histologically and radiologically.
  • [MeSH-major] Bone Neoplasms / pathology. Histiocytoma, Benign Fibrous / pathology. Osteosarcoma / diagnosis


46. Meis-Kindblom JM: Clear cell sarcoma of tendons and aponeuroses: a historical perspective and tribute to the man behind the entity. Adv Anat Pathol; 2006 Nov;13(6):286-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ultrastructural and immunohistochemical studies have shown melanocytic differentiation, whereas molecular genetic studies have shown cytogenetic rearrangements resulting in a EWSR1-ATF1 fusion gene that is characteristic but not entirely unique for clear cell sarcoma (similar fusion genes are also seen in angiomatoid fibrous histiocytoma).

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17075294.001).
  • [ISSN] 1072-4109
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Publication-type] Biography; Historical Article; Journal Article; Portraits; Review
  • [Publication-country] United States
  • [Number-of-references] 33
  • [Personal-name-as-subject] Enzinger F
  •  go-up   go-down


47. Young CC, Hupfer H, Siering C, Ho MJ, Arun AB, Lai WA, Rekha PD, Shen FT, Hung MH, Chen WM, Yassin AF: Azospirillum rugosum sp. nov., isolated from oil-contaminated soil. Int J Syst Evol Microbiol; 2008 Apr;58(Pt 4):959-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Azospirillum rugosum sp. nov., isolated from oil-contaminated soil.
  • The taxonomic status of a light-orange-coloured bacterial isolate from an oil-contaminated soil sample was characterized by using a polyphasic taxonomic approach.
  • Comparative analysis of 16S rRNA gene sequences demonstrated that the isolate belonged phylogenetically to the genus Azospirillum, with Azospirillum canadense, Azospirillum brasilense and Azospirillum doebereinerae as its closest phylogenetic relatives (97.3, 97.0 and 97.0 % similarity, respectively).
  • DNA-DNA pairing studies showed that the unidentified organism displayed 25.0, 17.0 and 19.0 % relatedness to the type strains of A. brasilense, A. canadense and A. doebereinerae, respectively.
  • The generic assignment was confirmed by chemotaxonomic data, which revealed a fatty acid profile that was characteristic of the genus Azospirillum, consisting of straight-chain saturated and unsaturated fatty acids with C18 : 1 omega 7c as the major fatty acid, and ubiquinone with ten isoprene units (Q-10) as the predominant respiratory quinone.
  • On the basis of both the phenotypic and molecular genetic evidence, it is proposed that the unknown isolate be classified as a representative of a novel species of the genus Azospirillum, for which the name Azospirillum rugosum sp. nov. is proposed.
  • The type strain is IMMIB AFH-6T (=CCUG 53966T=DSM 19657T).
  • [MeSH-major] Azospirillum / classification. Azospirillum / isolation & purification
  • [MeSH-minor] DNA, Bacterial / genetics. Fatty Acids / metabolism. Fuel Oils. Genes, Bacterial. Molecular Sequence Data. Phenotype. Phylogeny. RNA, Bacterial / genetics. RNA, Ribosomal, 16S / genetics. Soil Microbiology. Soil Pollutants / metabolism. Species Specificity. Terminology as Topic. Ubiquinone / metabolism

  • SILVA. SILVA SSU Database .
  • StrainInfo. culture/stock collections - online strain list (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18398202.001).
  • [ISSN] 1466-5026
  • [Journal-full-title] International journal of systematic and evolutionary microbiology
  • [ISO-abbreviation] Int. J. Syst. Evol. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Bacterial; 0 / Fatty Acids; 0 / Fuel Oils; 0 / RNA, Bacterial; 0 / RNA, Ribosomal, 16S; 0 / Soil Pollutants; 1339-63-5 / Ubiquinone
  •  go-up   go-down


48. Ren L, Guo SP, Zhou XG, Chan JK: Angiomatoid fibrous histiocytoma: first report of primary pulmonary origin. Am J Surg Pathol; 2009 Oct;33(10):1570-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma: first report of primary pulmonary origin.
  • Angiomatoid fibrous histiocytoma is an uncommon soft tissue tumor most frequently affecting the deep dermis and subcutis of the extremities in children and young adults.
  • Histologically, the tumor was composed of multiple cellular nodules surrounded by a fibrous pseudocapsule and peritumoral lymphoplasmacytic infiltrates.
  • It is important to recognize that angiomatoid fibrous histiocytoma can occur in the lung because its histologic features are rather nondescript and thus can be mistaken for other tumors such as meningioma, inflammatory myofibroblastic tumor, and follicular dendritic cell sarcoma.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / pathology. Lung Neoplasms / pathology

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19654501.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / EWS-ATF1 fusion protein, human; 0 / Oncogene Proteins, Fusion; 0 / Transcription Factors
  •  go-up   go-down


49. Sánchez de Toledo Sancho J, Fàbrega Sabaté J, Marhuenda Irastorza C, Lucaya Layret X, Torán Fuentes N, Gros Subias L, Sábado Alvarez C: [Castleman disease]. An Pediatr (Barc); 2005 Jul;63(1):68-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Castleman disease].
  • [Transliterated title] Enfermedad de Castleman.
  • Castleman disease or angiofollicular hyperplasia is a rare disorder included in the group of lymphoproliferative disorders.
  • This entity was originally described by Castleman in 1956.
  • The etiology remains unknown but it is postulated to be a reactive lymphoid hyperplasia due to chronic antigenic stimulation caused by a viral infection.
  • The disease presents in young adults and is more frequent in women; it is exceptionally rare in the pediatric age group.
  • It is classified into two clinical groups (localized disease and disseminated disease) and there are two histologic variants (hyaline-vascular and plasma cell Castleman disease).
  • Localized disease is usually asymptomatic, has a good prognosis, and is the most common presentation in pediatric patients, usually corresponding to highly vascularized mediastinal masses.
  • Resection of the mass, which is curative, is associated with a high risk of blood loss.
  • Recently, preoperative arteriography with embolization has been used satisfactorily in the preoperative management of these tumors.
  • We present a case of localized Castleman disease in a 12-year-old girl satisfactorily treated with embolization before curative resection.
  • [MeSH-major] Giant Lymph Node Hyperplasia / therapy
  • [MeSH-minor] Child. Embolization, Therapeutic. Female. Humans. Mediastinum

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15989874.001).
  • [ISSN] 1695-4033
  • [Journal-full-title] Anales de pediatría (Barcelona, Spain : 2003)
  • [ISO-abbreviation] An Pediatr (Barc)
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


50. Filingeri V, Gravante G, Marino B, Fratoni S, Schiaroli S: A rare case of cystic variety of angiomatoid fibrous histiocytoma. Eur Rev Med Pharmacol Sci; 2010 Oct;14(10):887-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare case of cystic variety of angiomatoid fibrous histiocytoma.
  • A rare case of cystic angiomatoid fibrous histiocytoma of the thigh in a 13-years-old girl is reported.
  • [MeSH-major] Cysts / pathology. Histiocytoma, Malignant Fibrous / pathology

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Eur Rev Med Pharmacol Sci. 2010 Dec;14(12):1074. Gravante, G [corrected to Bellini, I]
  • [ErratumIn] Eur Rev Med Pharmacol Sci. 2011 Mar;15(3):352. Bellini, I [corrected to Gravante, G]
  • (PMID = 21222377.001).
  • [ISSN] 1128-3602
  • [Journal-full-title] European review for medical and pharmacological sciences
  • [ISO-abbreviation] Eur Rev Med Pharmacol Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


51. Hallor KH, Mertens F, Jin Y, Meis-Kindblom JM, Kindblom LG, Behrendtz M, Kalén A, Mandahl N, Panagopoulos I: Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer; 2005 Sep;44(1):97-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma.
  • Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that usually occurs in children and young adults.
  • [MeSH-major] Artificial Gene Fusion. Calmodulin-Binding Proteins / genetics. DNA-Binding Proteins / genetics. Histiocytoma, Benign Fibrous / genetics. Nuclear Proteins / genetics. RNA-Binding Proteins / genetics. Transcription Factors / genetics

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 Wiley-Liss, Inc.
  • (PMID = 15884099.001).
  • [ISSN] 1045-2257
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ATF1 protein, human; 0 / Activating Transcription Factor 1; 0 / Calmodulin-Binding Proteins; 0 / DNA Primers; 0 / DNA-Binding Proteins; 0 / EWSR1 protein, human; 0 / MITF protein, human; 0 / Microphthalmia-Associated Transcription Factor; 0 / Nuclear Proteins; 0 / RNA-Binding Proteins; 0 / Transcription Factors; 0 / regulatory factor X transcription factors
  •  go-up   go-down


52. Bishop J: Students grapple with life and death issues. Health Estate; 2010 Oct;64(9):47-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Students grapple with life and death issues.
  • The 2010 Architects for Health (AfH) Student Health Design Awards, presented recently at the RIBA's London headquarters, saw the highest number of entries--at nearly 100--in the event's four-year history, with architecture and interior design students from all over the world demonstrating their talent, imagination, and creative skills, in the quest for the top prize.
  • Jaime Bishop, a director of Fleet Architects, AfH Executive board member, and the competition's organiser, outlines the Awards' key aims, describes the shortlisted and winning entries, discusses how candidates addressed the brief, and explains how the judges selected this year's winner and two runners-up.
  • [MeSH-major] Awards and Prizes. Facility Design and Construction. Students
  • [MeSH-minor] Cemeteries. Great Britain. Hospices. Rehabilitation Centers. Substance Abuse Treatment Centers

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21058620.001).
  • [Journal-full-title] Health estate
  • [ISO-abbreviation] Health Estate
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


53. Architects of a brighter future. Health Estate; 2008 Oct;62(9):81-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Architects of a brighter future.
  • An imaginative scheme for a children's speech and language clinic to be sited in a part of Newcastle Upon Tyne rich in history, and a design for a new oncology centre, in Breda, Holland, conceived to help "break the taboo that shrouds cancer" won the student architects the first and second prizes respectively in the 2008 Architects for Health (AfH) Student Awards.
  • Health Estate Journal reports.
  • [MeSH-major] Cancer Care Facilities. Facility Design and Construction. Hospital Design and Construction
  • [MeSH-minor] Articulation Disorders / rehabilitation. Awards and Prizes. Child Health Services. Child, Preschool. Humans. Students

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18988619.001).
  • [Journal-full-title] Health estate
  • [ISO-abbreviation] Health Estate
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


54. Martelli L, Collini P, Meazza C, Bianchi A, Salvini F, Zaffignani E, Favini F, Casanova M, Ferrari A: Angiomatoid fibrous histiocytoma in an HIV-positive child. J Pediatr Hematol Oncol; 2008 Mar;30(3):242-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma in an HIV-positive child.
  • Children with human immunodeficiency virus are at higher risk of developing tumor than the general population, non-Hodgkin lymphoma and Kaposi sarcoma being the most frequent malignant tumor in these patients.
  • The report describes the case of a human immunodeficiency virus-seropositive girl who developed an angiomatoid fibrous histiocytoma of the soft part of the right knee.
  • [MeSH-major] HIV Infections / complications. Hemangioma / diagnosis. Histiocytoma, Malignant Fibrous / diagnosis. Knee / pathology


55. Ochalski PG, Edinger JT, Horowitz MB, Stetler WR, Murdoch GH, Kassam AB, Engh JA: Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage. J Neurosurg; 2010 May;112(5):978-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage.
  • Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue neoplasm that most commonly appears in the limbs, typically affecting children and young adults.
  • [MeSH-major] Angiomatosis / complications. Angiomatosis / pathology. Cerebral Hemorrhage / complications. Cerebral Hemorrhage / pathology. Histiocytoma, Benign Fibrous / complications. Histiocytoma, Benign Fibrous / pathology

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19731989.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Rossi S, Szuhai K, Ijszenga M, Tanke HJ, Zanatta L, Sciot R, Fletcher CD, Dei Tos AP, Hogendoorn PC: EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res; 2007 Dec 15;13(24):7322-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.
  • PURPOSE: Angiomatoid fibrous histiocytoma (AFH) is a low-grade mesenchymal neoplasm which usually occurs in children and adolescents.
  • [MeSH-major] Cyclic AMP Response Element-Binding Protein / genetics. Histiocytoma, Malignant Fibrous / genetics. Oncogene Proteins, Fusion / genetics. Soft Tissue Neoplasms / genetics. Transcription Factors / genetics

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18094413.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CREB1 protein, human; 0 / Cyclic AMP Response Element-Binding Protein; 0 / EWS-ATF1 fusion protein, human; 0 / Oncogene Proteins, Fusion; 0 / Transcription Factors
  •  go-up   go-down


57. Patrizi A, Tabanelli M, Filippi G, Gurioli C, Nozza P, Savoia F, Dalmonte P, Misciali C: An angiomatoid fibrous histiocytoma over the left pre auricular region in a 13-year-old boy. Dermatol Online J; 2010;16(5):4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An angiomatoid fibrous histiocytoma over the left pre auricular region in a 13-year-old boy.
  • An incisional biopsy was performed and revealed an angiomatoid fibrous histiocytoma (AFH).
  • Angiomatoid fibrous histiocytoma (AFH) is a rare tumor of the soft tissue with fibrohistiocytic and vascular differentiation that shows an intermediate malignancy grade, mainly occurs in patients younger than 20 years of age, and is usually localized on the extremities.
  • Angiomatoid fibrous histiocytoma is considered to be a tumor of intermediate malignancy because of its less aggressive course in contrast to conventional malignant fibrous histiocytoma (MFH).
  • [MeSH-major] Histiocytoma, Malignant Fibrous / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20492821.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Beckers D, Thomas M, Jamart J, Francois I, Maes M, Lebrethon MC, De Waele K, Tenoutasse S, De Schepper J: Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience. Eur J Endocrinol; 2010 Mar;162(3):483-90
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
  • OBJECTIVES: The treatment of brain tumors in childhood is frequently complicated by growth retardation with a high proportion of irradiation (Irr)-induced GH deficiency (GHD) resulting in reduced adult final height (AFH) even after GH therapy (GHT).
  • In order to optimize future GHT protocols, more information on the factors influencing the growth response to GH in these children is needed.
  • This retrospective study evaluated AFH and influencing auxological and treatment factors of a standardized daily biosynthetic GHT in childhood survivors of brain tumors with documented GHD after brain Irr.
  • DESIGN AND METHODS: From the Belgian GH Registry, 57 children survivors of a brain tumor outside the hypothalamo-pituitary area with available AFH were stratified into two groups depending on cranial (C-Irr; n=25) or craniospinal (CS-Irr; n=32) Irr.
  • RESULTS: In the C-Irr patients, results showed an AFH of -0.8 (-2.5, 1.4) SDS (median (range)) and in the CS-Irr patients, results showed a significantly (P<0.001) lower AFH of -1.8 (-4.2, 0.0) SDS.
  • AFH SDS corrected for mid-parental height (MPH) in the C-Irr group was -0.5 (-2.2, 0.9) and -1.5 (-3.6, 0.0) SDS in the CS-Irr group.
  • AFH was positively correlated with age at end of tumor therapy, height SDS at start GHT, height gain SDS first year GHT, and negatively correlated with CS-Irr.
  • CONCLUSIONS: GHT failed to restore adult height to MPH in nearly half of Irr-induced GHD patients for brain tumor, especially those receiving CS-Irr, irradiated at a younger age or shorter at start GHT.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • ORBi (University of Liege). Free full Text at ORBi .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19969557.001).
  • [ISSN] 1479-683X
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 12629-01-5 / Human Growth Hormone
  •  go-up   go-down


59. Lai EC, Chung KM, Chiu HF, Lau WY: Angiomatoid fibrous histiocytoma in the neck. ANZ J Surg; 2006 Jun;76(6):538
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma in the neck.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Histiocytoma, Malignant Fibrous / pathology


60. Godinho SI, Maywood ES, Shaw L, Tucci V, Barnard AR, Busino L, Pagano M, Kendall R, Quwailid MM, Romero MR, O'neill J, Chesham JE, Brooker D, Lalanne Z, Hastings MH, Nolan PM: The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science; 2007 May 11;316(5826):897-900
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period.
  • By screening N-ethyl-N-nitrosourea-mutagenized animals for alterations in rhythms of wheel-running activity, we identified a mouse mutation, after hours (Afh).
  • The mutation, a Cys(358)Ser substitution in Fbxl3, an F-box protein with leucine-rich repeats, results in long free-running rhythms of about 27 hours in homozygotes.
  • Circadian transcriptional and translational oscillations are attenuated in Afh mice.
  • The Afh allele significantly affected Per2 expression and delayed the rate of Cry protein degradation in Per2::Luciferase tissue slices.
  • Our in vivo and in vitro studies reveal a central role for Fbxl3 in mammalian circadian timekeeping.
  • [MeSH-major] Circadian Rhythm. F-Box Proteins / genetics. F-Box Proteins / physiology. Point Mutation
  • [MeSH-minor] ARNTL Transcription Factors. Amino Acid Sequence. Amino Acid Substitution. Animals. Basic Helix-Loop-Helix Transcription Factors / genetics. Basic Helix-Loop-Helix Transcription Factors / metabolism. CLOCK Proteins. COS Cells. Cell Cycle Proteins / genetics. Cell Cycle Proteins / metabolism. Cercopithecus aethiops. Crosses, Genetic. Cryptochromes. Female. Flavoproteins / genetics. Flavoproteins / metabolism. Gene Expression Regulation. Liver / metabolism. Lung / metabolism. Male. Mice. Mice, Inbred BALB C. Mice, Inbred C3H. Molecular Sequence Data. Nuclear Proteins / genetics. Nuclear Proteins / metabolism. Period Circadian Proteins. Suprachiasmatic Nucleus / metabolism. Trans-Activators / genetics. Trans-Activators / metabolism. Transcription Factors / genetics. Transcription Factors / metabolism. Transcription, Genetic

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • SciCrunch. Marmoset Gene list: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17463252.001).
  • [ISSN] 1095-9203
  • [Journal-full-title] Science (New York, N.Y.)
  • [ISO-abbreviation] Science
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MC/ U105170643; United Kingdom / Medical Research Council / / MC/ U142684172; United Kingdom / Medical Research Council / / MC/ U142684173; United Kingdom / Medical Research Council / / MC/ U142684175
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ARNTL Transcription Factors; 0 / Arntl protein, mouse; 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Cell Cycle Proteins; 0 / Cryptochromes; 0 / F-Box Proteins; 0 / Fbxl3 protein, mouse; 0 / Flavoproteins; 0 / Nuclear Proteins; 0 / Per1 protein, mouse; 0 / Per2 protein, mouse; 0 / Period Circadian Proteins; 0 / Trans-Activators; 0 / Transcription Factors; EC 2.3.1.48 / CLOCK Proteins; EC 2.3.1.48 / Clock protein, mouse
  •  go-up   go-down


61. Nath A, Garg S: Adolescent friendly health services in India: A need of the hour. Indian J Med Sci; 2008 Nov;62(11):465-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adolescent friendly health services in India: A need of the hour.
  • Adolescents account for almost one third of India's population.
  • They are prone to suffer from reproductive and sexual health, nutritional, mental and behavioral problems.
  • Health services which cater exclusively to the needs of adolescents are scanty and concentrated in urban areas.
  • Adolescent Friendly Health Services (AFHS) which provide a broad range of preventive, promotive and curative services under one roof can help to ensure improved availability, accessibility and utilization of health services.
  • AFHS is being initiated by governmental, private and non-governmental organizations.
  • Lessons to improve the quality of AFHS could be further learnt from evaluation of pilot projects and success stories of similar initiatives in other countries.
  • [MeSH-major] Adolescent Health Services / standards. Health Services Accessibility / standards. Health Services Needs and Demand. Quality of Health Care / standards
  • [MeSH-minor] Adolescent. Female. Humans. India. Male

  • MedlinePlus Health Information. consumer health - Teen Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19265240.001).
  • [ISSN] 0019-5359
  • [Journal-full-title] Indian journal of medical sciences
  • [ISO-abbreviation] Indian J Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


62. Zavarzina DG, Kolganova TV, Bulygina ES, Kostrikina NA, Turova TP, Zavarzin GA: [Geoalkalibacter ferrihydriticus gen. nov., sp. nov., the first alkaliphilic representative of the family Geobacteraceae, isolated from a soda lake]. Mikrobiologiia; 2006 Nov-Dec;75(6):775-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Geoalkalibacter ferrihydriticus gen. nov., sp. nov., the first alkaliphilic representative of the family Geobacteraceae, isolated from a soda lake].
  • Investigation of iron reduction in bottom sediments of alkaline soda lakes resulted in the isolation of a new obligately anaerobic iron-reducing bacterium, strain Z-0531, from Lake Khadyn (Tuva Republic, Russia) sediment samples.
  • The cells of strain Z-0531 are short (1.0-1.5 by 0.3-0.5 microm), motile, non-spore-forming, gram-negative rods.
  • The isolate is an obligate alkaliphile, developing in the pH range of 7.8-10.0, with an optimum at pH 8.6.
  • It does not require NaCl but grows at NaCl concentrations of 0-50 g/1l.
  • It can oxidize acetate with such electron acceptors as amorphous Fe(llI) hydroxide (AFH), EDTA-Fe(III), anthraquinone-2,6-disulfonate (quinone), Mn(IV), and S(0).
  • On media with EDTA-Fe(III), the isolate can oxidize, apart from acetate, ethanol, pyruvate, oxalate, arginine, tartrate, lactate, propionate, and serine.
  • H2 is not utilized.
  • The reduced products formed during growth with AFH are siderite or magnetite, depending on the growth conditions.
  • The isolate is incapable of fermenting sugars, peptides, and amino acids.
  • Yeast extract or vitamins are required as growth factors.
  • The organism is capable of dinitrogen fixation and harbors the nifH gene.
  • The DNA G+C content is 55.3 mol %.
  • 16S rRNA analysis places strain Z-0531 into the family Geobacteraceae.
  • Its closest relative (93% similarity) is Desulfuromonas palmitatis.
  • Based on phenotypic distinctions and phylogenetic position, it is proposed that strain Z-0531 be assigned to the new genus and species Geoalkalibacter ferrihydriticus gen. nov., sp. nov.
  • [MeSH-major] Fresh Water / microbiology. Geobacter / isolation & purification. Water Microbiology
  • [MeSH-minor] Acetates / metabolism. Alkalies. Base Composition. Culture Media. DNA, Bacterial / genetics. Hydrogen-Ion Concentration. Iron / metabolism. Nitrogen Fixation. Oxidation-Reduction. Phylogeny. RNA, Bacterial / genetics. RNA, Ribosomal, 16S / genetics. Siberia. Species Specificity

  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • SILVA. SILVA SSU Database .
  • StrainInfo. culture/stock collections - online strain list (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17205802.001).
  • [ISSN] 0026-3656
  • [Journal-full-title] Mikrobiologiia
  • [ISO-abbreviation] Mikrobiologiia
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Acetates; 0 / Alkalies; 0 / Culture Media; 0 / DNA, Bacterial; 0 / RNA, Bacterial; 0 / RNA, Ribosomal, 16S; E1UOL152H7 / Iron
  •  go-up   go-down


63. Grogg KL, Macon WR, Kurtin PJ, Nascimento AG: A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol; 2005 Feb;18(2):260-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We evaluated staining for antibodies directed against these two antigens in 202 spindle cell tumors, including cases of follicular dendritic cell tumor (n=14), interdigitating dendritic cell tumor (n=7), leiomyosarcoma (n=17), inflammatory myofibroblastic tumor (n=13), inflammatory pseudotumor (n=2), spindle cell thymoma (n=17), synovial sarcoma (n=11), fibrosarcoma (n=14), liposarcoma (n=27), gastrointestinal stromal tumor (n=13), malignant fibrous histiocytoma (n=18), angiomatoid fibrous histiocytoma (n=4), angiosarcoma (n=10), malignant peripheral nerve sheath tumor (n=8), malignant melanoma (n=16), and spindle cell carcinoma (n=11).
  • Clusterin staining was least reliable in distinguishing follicular dendritic cell tumor from spindle cell thymoma or malignant fibrous histiocytoma, but these are entities that usually can be distinguished by clinical and morphologic data.


64. Castelo PM, Bonjardim LR, Pereira LJ, Gavião MB: Facial dimensions, bite force and masticatory muscle thickness in preschool children with functional posterior crossbite. Braz Oral Res; 2008 Jan-Mar;22(1):48-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Facial dimensions, bite force and masticatory muscle thickness in preschool children with functional posterior crossbite.
  • Posterior crossbite may affect craniofacial growth and development.
  • Thus, this study aimed to associate facial dimensions (by standardized frontal photographs) to masseter and anterior portion of the temporal muscle thickness (by ultrasonography) and maximal bilateral bite force in 49 children with deciduous and early mixed dentitions.
  • They were distributed in four groups: deciduous-normal occlusion (DNO, n = 15), deciduous-crossbite (DCB, n = 10), mixed-normal occlusion (MNO, n = 13) and mixed-crossbite (MCB, n = 11).
  • Anterior facial height (AFH), bizygomatic width (FWB), and intergonial width (FWI) were determined and associated with muscle thickness and bite force, applying Pearsons coefficients and multiple logistic regression, with age, gender, body weight and height as the covariates.
  • FWB and FWI were correlated positively with the masseter thickness, whereas AFH/FWB and AFH/FWI ratios had negative correlation, except in the DNO group.
  • The correlation between AFH/FWB and bite force in the MCB group was significantly negative.
  • A higher AFH/FWB in MNO and MCB led to a significantly higher probability for functional crossbite development.
  • In the studied sample, it was observed that children in the early mixed dentition with a long-face trend showed lower bite force and higher probability to present functional posterior crossbite, without significant influence of the covariates.
  • [MeSH-major] Bite Force. Dentition, Mixed. Facial Bones / anatomy & histology. Malocclusion, Angle Class II / physiopathology. Mandible / physiopathology. Masseter Muscle / physiopathology
  • [MeSH-minor] Age Distribution. Body Height. Body Weight. Child. Child, Preschool. Female. Humans. Logistic Models. Male. Multivariate Analysis. Sex Distribution

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18425245.001).
  • [ISSN] 1807-3107
  • [Journal-full-title] Brazilian oral research
  • [ISO-abbreviation] Braz Oral Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  •  go-up   go-down


65. Pavuk M, Patterson DG Jr, Turner WE, Needham LL, Ketchum NS: Polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and dioxin-like polychlorinated biphenyls (PCBs) in the serum of US Air Force veterans in 2002. Chemosphere; 2007 May;68(1):62-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and dioxin-like polychlorinated biphenyls (PCBs) in the serum of US Air Force veterans in 2002.
  • We measured levels of PCDDs, PCDFs, non-ortho, and mono-ortho substituted PCBs in 106 US Air Force Vietnam veterans, participants of the Air Force Health Study (AFHS) who attended the final medical examination in 2002.
  • Twelve veterans were Ranch Hands involved in aerial spraying of herbicides in Vietnam (1962-1971), and 94 were Comparisons who flew transport missions in Southeast Asia (SEA) during the same time period.
  • These veterans had no previous 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) measurement because they had not attended any of the previous AFHS examinations, or their previous measurements were missing or not valid.
  • The mean TCDD levels in 2002 were 1.7 pg/g lipid in Comparisons and 5.5 pg/g lipid in Ranch Hands.
  • The mean PCDD toxic equivalent - TEQ (1997) in Comparisons was 12.6 pg/g lipid, 5.4 pg/g lipid for PCDFs, 5.2 pg/g lipid for non-ortho PCBs, and 9.4 pg/g lipid for mono-ortho PCBs, with a total mean TEQ (1997) of 32.6 pg/g lipid.
  • Corresponding mean TEQs in Ranch Hands were 15.5 pg/g lipid for PCDDs, 4.6 pg/g lipid for PCDFs, 2.2 pg/g lipid for non-ortho PCBs, and 9.3 pg/g lipid for mono-ortho PCBs, yielding the total mean TEQ (1997) of 31.6pg/g lipid.
  • Using the re-evaluated 2005 WHO TEFs, the total mean TEQs (2005) decreased by about 28% in both Comparisons and Ranch Hands, to 23.6 pg/g lipid and 22.8 pg/g lipid, respectively.
  • This was mainly due to changes of TEFs for the group of mono-ortho PCBs, which decreased the mono-ortho PCBs TEQs by almost 90% in both Ranch Hands and Comparisons.
  • [MeSH-major] Benzofurans / blood. Military Personnel. Polychlorinated Biphenyls / blood. Polychlorinated Dibenzodioxins / analogs & derivatives. Veterans
  • [MeSH-minor] Adult. Agriculture. Dibenzofurans, Polychlorinated. Dioxins / blood. Humans. Male. Prospective Studies. United States / ethnology. Vietnam


66. Mansfield A, Larson B, Stafford SL, Shives TC, Haddock MG, Dingli D: Angiomatoid fibrous histiocytoma in a 25-year-old male. Rare Tumors; 2010;2(2):e20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma in a 25-year-old male.
  • Angiomatoid fibrous histiocytoma (AFH) is a rare disease that is often misdiagnosed initially.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139823.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994511
  • [Keywords] NOTNLM ; angiomatoid fibrous histiocytoma / soft tissue tumor.
  •  go-up   go-down


67. Wang HY, Fan QH, Gong QX, Wang Z: [Clinicopathologic characteristics of hemangiopericytoma/solitary fibrous tumor with giant cells]. Zhonghua Bing Li Xue Za Zhi; 2009 Mar;38(3):169-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathologic characteristics of hemangiopericytoma/solitary fibrous tumor with giant cells].
  • OBJECTIVE: To study the pathological characteristics, diagnosis and differential diagnoses of hemangiopericytoma-solitary fibrous tumor with giant cells.
  • METHODS: Pathological characteristics of seven cases of orbital and extraorbital hemangiopericytoma-solitary fibrous tumors with giant cells were evaluated by HE and immunohistochemistry (EnVision method).
  • CONCLUSIONS: Hemangiopericytoma-solitary fibrous tumor with giant cells is an intermediate soft tissue tumor.
  • Histologically, the tumor should be distinguished from giant cell fibroblastoma, pleomorphic hyalinzing angiectatic tumor of soft part and angiomatoid fibrous histiocytoma.
  • [MeSH-major] Hemangiopericytoma / pathology. Orbital Neoplasms / pathology. Solitary Fibrous Tumors / pathology
  • [MeSH-minor] Adult. Antigens, CD / metabolism. Antigens, CD34 / metabolism. Cell Adhesion Molecules / metabolism. Dermatofibrosarcoma / pathology. Diagnosis, Differential. Female. Follow-Up Studies. Histiocytoma, Benign Fibrous / pathology. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Recurrence, Local. Proto-Oncogene Proteins c-bcl-2 / metabolism. Soft Tissue Neoplasms / pathology. Solitary Fibrous Tumor, Pleural / metabolism. Solitary Fibrous Tumor, Pleural / pathology. Solitary Fibrous Tumor, Pleural / surgery. Young Adult

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19575851.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD34; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules; 0 / Proto-Oncogene Proteins c-bcl-2
  •  go-up   go-down


68. Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, Ladanyi M: EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer; 2007 Dec;46(12):1051-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
  • The molecular hallmark of angiomatoid fibrous histiocytoma (AFH) is not well defined, with only six cases with specific gene fusions reported to date, consisting of either FUS-ATF1 or EWSR1-ATF1.
  • EWSR1-ATF1, identified in some AFH cases, is the most common genetic abnormality in soft tissue clear cell sarcoma.
  • [MeSH-major] Calmodulin-Binding Proteins / genetics. Cyclic AMP Response Element-Binding Protein / genetics. Gene Fusion. Histiocytoma, Malignant Fibrous / genetics. RNA-Binding Proteins / genetics

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17724745.001).
  • [ISSN] 1045-2257
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CREB1 protein, human; 0 / Calmodulin-Binding Proteins; 0 / Cyclic AMP Response Element-Binding Protein; 0 / EWSR1 protein, human; 0 / RNA-Binding Proteins
  •  go-up   go-down


69. Tanas MR, Rubin BP, Montgomery EA, Turner SL, Cook JR, Tubbs RR, Billings SD, Goldblum JR: Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases. Mod Pathol; 2010 Jan;23(1):93-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases.
  • Angiomatoid fibrous histiocytoma is a mesenchymal neoplasm of intermediate malignancy and uncertain histogenesis/line of differentiation, which occurs most commonly in the extremities of children to young adults.
  • It has a characteristic appearance characterized by a proliferation of histiocytoid cells with a lymphoid cuff and fibrous pseudocapsule, simulating the appearance of a neoplasm occurring within a lymph node.
  • Angiomatoid fibrous histiocytoma has been found to harbor three related translocations, a t(12;16)(q13;p11) resulting in a FUS/ATF1 fusion gene, t(12;22)(q13;q12) resulting in a EWSR1/ATF1 fusion, and t(2;22)(q33;q12) resulting in a EWSR1/CREB1 fusion.
  • We evaluated 18 cases of angiomatoid fibrous histiocytoma for rearrangements of EWSR1 and FUS by FISH, the largest series to date.
  • We found that 13 of 17 (76%) cases of angiomatoid fibrous histiocytoma harbored rearrangements of EWSR1; rearrangements of FUS were not detected in any of the cases.
  • This study affirms that the rearrangement of EWSR1 is a common genetic event in angiomatoid fibrous histiocytoma, and is thus useful diagnostically.
  • This study supports the fact that the rearrangement of FUS is present in only a small minority of angiomatoid fibrous histiocytomas.
  • Although it is possible that these cases contained cryptic rearrangements of EWSR1 or FUS that were not detectable by our FISH probes, it also raises the possibility that another translocation/gene fusion may be present in angiomatoid fibrous histiocytoma.
  • [MeSH-major] Biomarkers, Tumor / genetics. Calmodulin-Binding Proteins / genetics. Histiocytoma, Malignant Fibrous / genetics. In Situ Hybridization, Fluorescence. RNA-Binding Protein FUS / genetics. RNA-Binding Proteins / genetics


70. Lau EY, Sampson WJ, Townsend GC, Hughes T: An evaluation of maxillary and mandibular rotational responses with the Clark twin block appliance. Aust Orthod J; 2009 May;25(1):48-58
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An evaluation of maxillary and mandibular rotational responses with the Clark twin block appliance.
  • AIMS: To evaluate the dentofacial changes and growth rotational responses of Angle Class II division 1 patients treated with the Clark twin block functional appliance.
  • METHOD: This retrospective study comprised 13 boys (8.77 +/- 0.86 years) and 13 girls (8.75 +/- 0.70 years) treated by one orthodontist with the Clark twin block appliance.
  • Selection was not biased by outcome and sample size power estimates exceeded 90 per cent.
  • Tracings made on the pretreatment (T1), post-treatment (T2) and observation (T3) radiographs were superimposed on anatomically stable landmarks and the dentofacial changes and growth rotational responses compared.
  • The data were tested for normal distribution and sexual dimorphism.
  • Pearson correlation analyses of the treatment and observation phases were performed.
  • RESULTS: In light of the few sex differences and lack of any consistent trends, the data for the boys and girls were combined.
  • Treatment reduced the overbite, overjet and achieved Class II correction through combinations of maxillary incisor uprighting (U1-SN: -5.3 +/- 5.30), lower incisor proclination (L1-MP: 6.6 +/- 6.80), facial height increase (AFH: 5.1 +/- 4.6 mm), ramal lengthening (Co-Go: 3.3 +/- 2.4 mm) and mandibular length increase (Co-Pog: 5.9 +/- 4.6 mm).
  • During the observation period, similar growth changes were recorded, but the overbite (2.9 +/- 1.9 mm) and overjet (3.6 +/- 2.0 mm) increased due to some reversal of the treatment-induced incisor angulation changes.
  • Over the treatment period (T1 to T2), the angles between the cranial base and maxillary (maxillary rotation) and mandibular stable structures (mandibular internal rotation) reduced by -0.1 +/- 1.2 degrees and -0.3 +/- 2.5 degrees, respectively.
  • The angles between mandibular stable structures and Go-Me (mandibular external rotation) and SN-GoMe (mandibular total rotation) increased by 0.6 +/- 1.7 degrees and 0.9 +/- 2.1 degrees, respectively.
  • Between T2 and T3, maxillary rotation, mandibular internal rotation and total mandibular rotation reduced -1.4 +/- 2.0 degrees, -2.4 +/- 2.5 degrees and -0.7 +/- 1.7 degrees, respectively.
  • Mandibular external rotation increased -1.8 +/- 2.0 degrees.
  • Mandibular total and internal rotation angles were significantly (p < 0.5) reduced at T2, but there were no significant associations between the rotations and dentofacial parameters during or following treatment.
  • CONCLUSIONS: On average, the maxillary and mandibular internal rotations were near zero during treatment, but the small and individually variable changes were not clearly associated with the Class II correction.
  • [MeSH-major] Malocclusion, Angle Class II / therapy. Mandible / physiology. Maxillofacial Development. Orthodontic Appliances, Functional. Orthodontics, Corrective / instrumentation
  • [MeSH-minor] Cephalometry / statistics & numerical data. Child. Face / anatomy & histology. Female. Humans. Male. Maxilla / physiology. Movement. Retrospective Studies. Vertical Dimension

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19634464.001).
  • [ISSN] 0587-3908
  • [Journal-full-title] Australian orthodontic journal
  • [ISO-abbreviation] Aust Orthod J
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  •  go-up   go-down


71. Weinreb I, Rubin BP, Goldblum JR: Pleomorphic angiomatoid fibrous histiocytoma: a case confirmed by fluorescence in situ hybridization analysis for EWSR1 rearrangement. J Cutan Pathol; 2008 Sep;35(9):855-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleomorphic angiomatoid fibrous histiocytoma: a case confirmed by fluorescence in situ hybridization analysis for EWSR1 rearrangement.
  • Angiomatoid fibrous histiocytoma (AFH) is a neoplasm of uncertain histogenesis with intermediate malignant potential.
  • The neoplasm is usually composed of a bland histiocytoid proliferation of cells with eosinophilic cytoplasm forming a syncytium, often surrounded by a dense fibrous pseudocapsule and lymphoid infiltrate, with abundant intralesional hemorrhage forming blood-filled spaces.
  • We present a diagnostically challenging case of AFH with pleomorphic features and minimal lymphoid and angiomatoid changes involving the superficial subcutis and deep dermis on the scalp of an 8-year-old boy.
  • [MeSH-major] Histiocytoma, Malignant Fibrous / pathology. Oncogene Proteins, Fusion / genetics. Soft Tissue Neoplasms / pathology. Transcription Factors / genetics

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18422688.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / EWS-ATF1 fusion protein, human; 0 / Oncogene Proteins, Fusion; 0 / RNA-Binding Protein FUS; 0 / Transcription Factors
  •  go-up   go-down


72. Cernik C, Channaiah D, Trevino J: Angiomatoid fibrous histiocytoma in a six-year-old child. Pediatr Dermatol; 2009 Sep-Oct;26(5):636-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Angiomatoid fibrous histiocytoma in a six-year-old child.
  • The histology is characterized by a fibrous capsule, surrounding lymphocytic infiltrate and blood-filled cystic spaces lined by flattened tumor cells.
  • [MeSH-major] Hemangioma / pathology. Histiocytoma, Malignant Fibrous / pathology. Skin Neoplasms / pathology


73. Hedrick SC, Sullivan JH, Sales AE, Gray SL: Mom and pop versus the big boys: adult family homes as providers of Medicaid-funded residential care. J Aging Soc Policy; 2009 Jan-Mar;21(1):31-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mom and pop versus the big boys: adult family homes as providers of Medicaid-funded residential care.
  • This paper compares assisted living apartments (ALs), adult residential care facilities (ARCs), and small adult family homes (AFHs) for Medicaid residents in Washington State, with particular emphasis on the settings, staffing, services, and policies of AFHs.
  • We targeted for enrollment all residents entering an AFH, ARC, or AL setting on Medicaid/state funding in a three-county area of Washington State.
  • We obtained information on 199 settings, interviewing administrative and direct care providers.
  • AFHs are smaller than ARCs and ALs and less likely to be part of a chain, with no significant difference in staffing ratios of registered nurses and licensed practical nurses.
  • Sixty-four percent of AFH residents were receiving public funds compared to 32% of AL residents.
  • AFHs report admitting residents with more activities of daily living needs, health conditions, and behavior problems.
  • They are less likely to have autonomy-related policies, and they provide more services and fewer activities.
  • While attention should continue to be paid to staff supports, policy and practice should support the continued role of AFHs, which are of special interest because of their potential to provide more homelike, less costly care but with possible trade-offs compared to larger facilities.
  • [MeSH-major] Medicaid / statistics & numerical data. Ownership. Residential Facilities / organization & administration
  • [MeSH-minor] Environment. Humans. Personnel Staffing and Scheduling / organization & administration. Public Policy. United States

  • MedlinePlus Health Information. consumer health - Medicaid.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19197607.001).
  • [ISSN] 0895-9420
  • [Journal-full-title] Journal of aging & social policy
  • [ISO-abbreviation] J Aging Soc Policy
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


74. Kumari M, Fida M: Vertical facial and dental arch dimensional changes in extraction vs. non-extraction orthodontic treatment. J Coll Physicians Surg Pak; 2010 Jan;20(1):17-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vertical facial and dental arch dimensional changes in extraction vs. non-extraction orthodontic treatment.
  • OBJECTIVE: To compare the vertical facial and dental arch dimensional changes occurring with extraction and nonextraction orthodontic treatments.
  • STUDY DESIGN: Cross-sectional comparative study.
  • PLACE AND DURATION OF STUDY: The Aga Khan University Hospital, Karachi during the period 2003 to 2005.
  • METHODOLOGY: Data were collected using records of patients who visited the study setting during the study period.
  • Pre- and post-treatment lateral cephalographs and study casts of 81 orthodontic patients (41=non-extraction and 40=premolar extractions) were taken.
  • Variables used for evaluating vertical dimension were Frankfort mandibular plane angle (FMA), facial height (N-Me), facial height ratio (N-ANS/ANS-Me), soft tissue facial height (G' to Me'), soft tissue facial height ratio (G'-Sn'/zn'-Me'), upper first molar to palatal plane and lower first molar to mandibular plane distance, posterior facial height to anterior facial height ratio (PFH/AFH) and Y-axis.
  • Intercanine, interpremolar and intermolar widths and arch depths were also measured.
  • To evaluate the pre-treatment and posttreatment comparison within each group, paired t-tests were used.
  • For pre- and posttreatment comparisons between the extraction and non-extraction groups, independent sample t-tests were used.
  • RESULTS: The mean age was 15.8+/-1.5 years for non-extraction and 15.4+/-1.2 years for the extraction group.
  • There was no significant difference in the vertical dimensional changes between extraction and non-extraction treatments as it increased in both groups.
  • When comparing posttreatment arch dimensions, there was an increase in the maxillary intermolar width in the non-extraction group while the intermolar widths and arch depths decreased in the extraction group in both arches.
  • CONCLUSION: Vertical dimensional changes showed no significant difference between extraction and non-extraction groups.
  • Intermolar widths and arch depths decreased in both arches in the extraction group while the maxillary intermolar width increased in the non-extraction group.
  • [MeSH-major] Bicuspid / surgery. Dental Arch / anatomy & histology. Face / anatomy & histology. Orthodontics, Corrective. Tooth Extraction
  • [MeSH-minor] Adolescent. Female. Humans. Male. Malocclusion / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20141687.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


75. Yu H, Wang CF, Yang WT, Zhu XZ: [Angiomatoid fibrous histiocytoma: report of 5 cases with review of literature]. Zhonghua Bing Li Xue Za Zhi; 2010 Apr;39(4):245-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Angiomatoid fibrous histiocytoma: report of 5 cases with review of literature].
  • OBJECTIVE: To study the clinicopathologic features, immunophenotype and differential diagnosis of angiomatoid fibrous histiocytoma (AFH).
  • Fibrillary neuropil-type intercellular material was identified in all cases and a fibrous pseudocapsule surrounded by lymphocytes and plasma cells was demonstrated in 3 cases.
  • CONCLUSIONS: AFH is a rare tumor of intermediate malignant potential.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aneurysm / metabolism. Aneurysm / pathology. Antigens, CD / metabolism. Antigens, Differentiation, Myelomonocytic / metabolism. Chemotherapy, Adjuvant. Child. Desmin / metabolism. Diagnosis, Differential. Female. Follow-Up Studies. Histiocytoma, Malignant Fibrous / pathology. Humans. Male. Radiotherapy, Adjuvant. Vimentin / metabolism. Young Adult

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20654123.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human; 0 / Desmin; 0 / Vimentin
  •  go-up   go-down


76. Lessa FC, Enoki C, Feres MF, Valera FC, Lima WT, Matsumoto MA: Breathing mode influence in craniofacial development. Braz J Otorhinolaryngol; 2005 Mar-Apr;71(2):156-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Breathing mode influence in craniofacial development.
  • AIM: The aim of this study was to evaluate the differences in facial proportions of nose and mouth breathing children using cephalometric analysis.
  • STUDY DESIGN: Transversal cohort.
  • MATERIAL AND METHOD: Sixty cephalometric radiographs from pediatric patients aged 6 to 10 years were used.
  • After otorhinolaryngological evaluation, patients were divided into two groups: Group I, with mouth breathing children and group II, with nose breathers.
  • Standard lateral cephalometric radiographs were obtained to evaluate facial proportions using the following measures: SN.GoGn, ArGo.GoMe, N-Me, N-ANS, ANS-Me and S-Go; and the following indexes: PFH-AFH ratio: S-Go/N-Me; LFH-AFH ratio: ANS-Me/N-Me and UFH-LFH ratio: N-ANS/ANS-Me.
  • RESULTS: It was observed that the measurements for the inclination of the mandibular plane (SN.GoGn) in mouth breathing children were statistically higher than those in nasal breathing children.
  • The posterior facial height was statistically smaller than the anterior one in mouth breathing children (PFH-AFH ratio).
  • Thus, the upper anterior facial height was statistically smaller than the lower facial height (UFH-LFH ratio).
  • CONCLUSION: We concluded that mouth breathing children tend to have higher mandibular inclination and more vertical growth.
  • These findings support the influence of the breathing mode in craniofacial development.
  • [MeSH-major] Facial Bones / growth & development. Respiration
  • [MeSH-minor] Cephalometry. Child. Cohort Studies. Cross-Sectional Studies. Female. Humans. Male. Maxillofacial Development. Mouth Breathing. Nose. Skull / anatomy & histology. Skull / growth & development

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16446911.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down






Advertisement